p-menthane - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	p-menthane	go back to main search page
Accession:	CHEBI:25826	browse the term
Definition:	A monoterpene that has formula C10H20.
Synonyms:	related_synonym:	1-Methyl-4-(propan-2-yl)cyclohexane; 1-isopropyl-4-methylcyclohexane; 1-methyl-4-(1-methylethyl)-cyclohexane; Formula=C10H20; InChI=1S/C10H20/c1-8(2)10-6-4-9(3)5-7-10/h8-10H,4-7H2,1-3H3; InChIKey=CFJYNSNXFXLKNS-UHFFFAOYSA-N; SMILES=CC1CCC(CC1)C(C)C; p-Menthan; para-menthane
	xref:	Beilstein:1900617; CAS:99-82-1; LIPID_MAPS_instance:LMPR0102090000

show annotations for term's descendants Sort by:
Rat (824) Mouse (826) Human (850) Chinchilla (0) Bonobo (0) Dog (2) Squirrel (0) Pig (1) Green Monkey (0) Naked Mole-rat (0) All
Genes (824)

(-)-alpha-phellandrene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

apoptosis antagonizing transcription factor

decreases expression

alpha phellandrene results in decreased expression of AATF mRNA

NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201

G

acid phosphatase 1

decreases expression

alpha phellandrene results in decreased expression of ACP1 mRNA

NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021

G

acyl-CoA synthetase short-chain family member 2

increases expression

alpha phellandrene results in increased expression of ACSS2 mRNA

NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675

G

ADAM metallopeptidase domain 18

decreases expression

alpha phellandrene results in decreased expression of ADAM18 mRNA

NCBI chr16:67,352,360...67,425,820
Ensembl chr16:67,352,416...67,425,248

G

ADAM metallopeptidase domain 3A

decreases expression

alpha phellandrene results in decreased expression of ADAM3 mRNA

NCBI chr16:67,299,949...67,349,970
Ensembl chr16:67,299,949...67,349,968

G

AFG2 AAA ATPase homolog A

decreases expression

alpha phellandrene results in decreased expression of AFG2A mRNA

NCBI chr 2:120,306,417...120,497,707
Ensembl chr 2:120,306,412...120,497,705

G

AKT serine/threonine kinase 1

decreases expression

alpha phellandrene results in decreased expression of AKT1 protein

NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921

G

aldehyde dehydrogenase 1 family, member L2

increases expression

alpha phellandrene results in increased expression of ALDH1L2 mRNA

NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776

G

aldolase, fructose-bisphosphate C

increases expression

alpha phellandrene results in increased expression of ALDOC mRNA

NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066

G

ankyrin repeat domain 49

decreases expression

alpha phellandrene results in decreased expression of ANKRD49 mRNA

NCBI chr 8:11,627,512...11,632,200
Ensembl chr 8:11,627,518...11,632,207

G

annexin A1

increases expression

alpha phellandrene results in increased expression of ANXA1 mRNA

NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343

G

annexin A9

decreases expression

alpha phellandrene results in decreased expression of ANXA9 mRNA

NCBI chr 2:182,873,185...182,884,501
Ensembl chr 2:182,872,929...182,883,374

G

adaptor related protein complex 3 subunit mu 2

increases expression

alpha phellandrene results in increased expression of AP3M2 mRNA

NCBI chr16:69,217,526...69,237,372
Ensembl chr16:69,217,633...69,235,431

G

arginase 2

increases expression

alpha phellandrene results in increased expression of ARG2 mRNA

NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378

G

Rho guanine nucleotide exchange factor 12

increases expression

alpha phellandrene results in increased expression of ARHGEF12 mRNA

NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366

G

arylsulfatase family, member K

decreases expression

alpha phellandrene results in decreased expression of ARSK mRNA

NCBI chr 2:5,574,319...5,631,451
Ensembl chr 2:5,574,322...5,631,467

G

aspartoacylase

increases expression

alpha phellandrene results in increased expression of ASPA mRNA

NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272

G

activating transcription factor 3

increases expression

alpha phellandrene results in increased expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

BCL2, apoptosis regulator

increases phosphorylation

alpha phellandrene results in increased phosphorylation of BCL2 protein

NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

beclin 1

increases phosphorylation

alpha phellandrene results in increased phosphorylation of BECN1 protein

NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742

G

Bcl2 modifying factor

increases expression

alpha phellandrene results in increased expression of BMF mRNA

NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145

G

BCL2 interacting protein 3

increases expression

alpha phellandrene results in increased expression of BNIP3 mRNA

NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359

G

biorientation of chromosomes in cell division 1

increases expression

alpha phellandrene results in increased expression of BOD1 mRNA

NCBI chr10:15,993,454...15,999,795
Ensembl chr10:15,993,454...15,999,787

G

BRCA1, DNA repair associated

decreases expression

alpha phellandrene results in decreased expression of BRCA1 protein

NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304

G

BTG anti-proliferation factor 2

increases expression

alpha phellandrene results in increased expression of BTG2 mRNA

NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628

G

calmodulin 2

increases expression

alpha phellandrene results in increased expression of CALM2 mRNA

NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
Ensembl chr15:7,091,567...7,104,287

G

calpain, small subunit 1

increases expression

alpha phellandrene results in increased expression of CAPNS1 mRNA

NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795

G

caprin family member 2

increases expression

alpha phellandrene results in increased expression of CAPRIN2 mRNA

NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830

G

caspase recruitment domain family, member 6

increases expression

alpha phellandrene results in increased expression of CARD6 mRNA

NCBI chr 2:54,194,343...54,206,902
Ensembl chr 2:54,195,739...54,206,846

G

calcium regulated heat stable protein 1

increases expression

alpha phellandrene results in increased expression of CARHSP1 mRNA

NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019

G

C-C motif chemokine ligand 5

increases expression

alpha phellandrene results in increased expression of CCL5 mRNA

NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377

G

cyclin G2

increases expression

alpha phellandrene results in increased expression of CCNG2 mRNA

NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830

G

C-C motif chemokine receptor like 2

increases expression

alpha phellandrene results in increased expression of CCRL2 mRNA

NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664

G

CD59b molecule

decreases expression

alpha phellandrene results in decreased expression of CD59A mRNA

NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847

G

CUB domain containing protein 2

increases expression

alpha phellandrene results in increased expression of CDCP2 mRNA

NCBI chr 5:121,877,581...121,894,203
Ensembl chr 5:121,877,581...121,894,203

G

cyclin-dependent kinase inhibitor 1A

increases expression

alpha phellandrene results in increased expression of CDKN1A mRNA

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin dependent kinase inhibitor 2D

increases expression

alpha phellandrene results in increased expression of CDKN2D mRNA

NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674

G

CASP8 and FADD-like apoptosis regulator

increases expression

alpha phellandrene results in increased expression of CFLAR mRNA

NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034

G

C-type lectin domain family 12, member A

decreases expression

alpha phellandrene results in decreased expression of CLEC12A mRNA

NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753

G

C-type lectin domain family 4, member D

decreases expression

alpha phellandrene results in decreased expression of CLEC4D mRNA

NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848

G

C-type lectin domain family 6, member A, pseudogene 1

decreases expression

alpha phellandrene results in decreased expression of CLEC4N mRNA

NCBI chr 4:156,539,408...156,559,032
Ensembl chr 4:156,539,408...156,558,605
Ensembl chr 4:156,539,408...156,558,605

G

clustered mitochondria homolog

decreases expression

alpha phellandrene results in decreased expression of CLUH mRNA

NCBI chr10:59,509,580...59,531,345
Ensembl chr10:59,509,726...59,531,345

G

cytidine/uridine monophosphate kinase 2

increases expression

alpha phellandrene results in increased expression of CMPK2 mRNA

NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183

G

complement C3b/C4b receptor 1 like

decreases expression

alpha phellandrene results in decreased expression of CR1L mRNA

NCBI chr13:106,606,952...106,660,442
Ensembl chr13:106,574,858...106,660,445

G

cysteine-rich secretory protein 1

decreases expression

alpha phellandrene results in decreased expression of CRISP1 mRNA

NCBI chr 9:20,741,775...20,768,796
Ensembl chr 9:20,741,777...20,768,796

G

cystatin F

decreases expression

alpha phellandrene results in decreased expression of CST7 mRNA

NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557

G

cystatin A

increases expression

alpha phellandrene results in increased expression of STFA1 mRNA

NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488

G

cathepsin G

decreases expression

alpha phellandrene results in decreased expression of CTSG mRNA

NCBI chr15:29,930,988...29,937,353
Ensembl chr15:29,931,003...29,937,353

G

C-X-C motif chemokine ligand 10

increases expression

alpha phellandrene results in increased expression of CXCL10 mRNA

NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975

G

cytochrome b561 family, member D2

decreases expression

alpha phellandrene results in decreased expression of CYB561D2 mRNA

NCBI chr 8:108,213,201...108,215,778
Ensembl chr 8:108,213,205...108,215,759

G

cytoplasmic FMR1 interacting protein 2

increases expression

alpha phellandrene results in increased expression of CYFIP2 mRNA

NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113

G

cytochrome P450, family 51

decreases expression

alpha phellandrene results in decreased expression of CYP51 mRNA

NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
Ensembl chr 6:30,036,865...30,055,410

G

developing brain homeobox 1

increases expression

alpha phellandrene results in increased expression of DBX1 mRNA

NCBI chr 1:99,348,638...99,354,173
Ensembl chr 1:99,349,608...99,354,038

G

dCMP deaminase

decreases expression

alpha phellandrene results in decreased expression of DCTD mRNA

NCBI chr16:44,066,952...44,098,654
Ensembl chr16:44,055,128...44,098,446

G

DNA-damage-inducible transcript 4

increases expression

alpha phellandrene results in increased expression of DDIT4 mRNA

NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105

G

DEAD-box helicase 31

decreases expression

alpha phellandrene results in decreased expression of DDX31 mRNA

NCBI chr 3:12,172,829...12,238,392
Ensembl chr 3:12,172,836...12,238,873

G

DEXD/H-box helicase 60

increases expression

alpha phellandrene results in increased expression of DDX60 mRNA

NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526

G

DNA fragmentation factor subunit beta

increases expression

alpha phellandrene results in increased expression of DFFB mRNA

NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628

G

diacylglycerol kinase, alpha

increases expression

alpha phellandrene results in increased expression of DGKA mRNA

NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110

G

dehydrogenase/reductase 1

increases expression

alpha phellandrene results in increased expression of DHRS1 mRNA

NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838

G

DEAH-box helicase 33

decreases expression

alpha phellandrene results in decreased expression of DHX33 mRNA

NCBI chr10:55,708,102...55,724,618
Ensembl chr10:55,705,756...55,724,567

G

DEXH-box helicase 58

increases expression

alpha phellandrene results in increased expression of DHX58 mRNA

NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525

G

dyskerin pseudouridine synthase 1

decreases expression

alpha phellandrene results in decreased expression of DKC1 mRNA

G

dual specificity phosphatase 1

increases expression

alpha phellandrene results in increased expression of DUSP1 mRNA

NCBI chr10:16,680,478...16,683,275

G

dual specificity phosphatase 6

increases expression

alpha phellandrene results in increased expression of DUSP6 mRNA

NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185

G

dynein light chain Tctex-type 3

increases expression

alpha phellandrene results in increased expression of DYNLT3 mRNA

NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139

G

egl-9 family hypoxia-inducible factor 3

increases expression

alpha phellandrene results in increased expression of EGLN3 mRNA

NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766

G

early growth response 1

increases expression

alpha phellandrene results in increased expression of EGR1 mRNA

NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766

G

eukaryotic translation initiation factor 5

decreases expression

alpha phellandrene results in decreased expression of EIF5 mRNA

NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656

G

elaC ribonuclease Z 2

decreases expression

alpha phellandrene results in decreased expression of ELAC2 mRNA

NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614

G

ELOVL fatty acid elongase 1

decreases expression

alpha phellandrene results in decreased expression of ELOVL1 mRNA

NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958

G

ELOVL fatty acid elongase 7

increases expression

alpha phellandrene results in increased expression of ELOVL7 mRNA

NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845

G

enolase 2

increases expression

alpha phellandrene results in increased expression of ENO2 mRNA

NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980

G

F-box protein 44

increases expression

alpha phellandrene results in increased expression of FBXO44 mRNA

NCBI chr 5:158,583,363...158,592,510
Ensembl chr 5:158,583,366...158,592,363

G

FGGY carbohydrate kinase domain containing

increases expression

alpha phellandrene results in increased expression of FGGY mRNA

NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017

G

FLVCR choline and heme transporter 1

decreases expression

alpha phellandrene results in decreased expression of FLVCR1 mRNA

NCBI chr13:102,586,263...102,608,647
Ensembl chr13:102,586,257...102,608,661

G

Fos proto-oncogene, AP-1 transcription factor subunit

increases expression

alpha phellandrene results in increased expression of FOS mRNA

NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036

G

forkhead box O1

increases expression

alpha phellandrene results in increased expression of FOXO1 mRNA

NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790

G

formyl peptide receptor 1

decreases expression

alpha phellandrene results in decreased expression of FPR1 mRNA

NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:58,747,246...58,756,559

G

ferritin heavy chain 1

increases expression

alpha phellandrene results in increased expression of FTH1 mRNA

NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424

G

ferritin light chain 1

increases expression

alpha phellandrene results in increased expression of FTL1 mRNA; alpha phellandrene results in increased expression of FTL2-PS mRNA

NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725
Ensembl chr10:95,936,387...95,939,725
Ensembl chr 2:95,936,387...95,939,725

G

FtsJ RNA 2'-O-methyltransferase 3

decreases expression

alpha phellandrene results in decreased expression of FTSJ3 mRNA

NCBI chr10:91,180,945...91,187,389
Ensembl chr10:91,180,696...91,187,397

G

frataxin

decreases expression

alpha phellandrene results in decreased expression of FXN mRNA

NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540

G

GABA type A receptor-associated protein

increases expression

alpha phellandrene results in increased expression of GABARAP mRNA

NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765

G

growth arrest and DNA-damage-inducible, alpha

increases expression

alpha phellandrene results in increased expression of GADD45A mRNA

NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115

G

growth arrest specific 5

decreases expression

alpha phellandrene results in decreased expression of GAS5 mRNA

NCBI chr13:73,303,611...73,306,932

G

guanylate binding protein family member 6

increases expression

alpha phellandrene results in increased expression of GBP6 mRNA

NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062
Ensembl chr14:4,730,453...4,839,062

G

GNAS complex locus

increases expression

alpha phellandrene results in increased expression of GNAS mRNA

NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262
Ensembl chr 3:163,071,417...163,127,262

G

G protein nucleolar 3

decreases expression

alpha phellandrene results in decreased expression of GNL3 mRNA

NCBI chr16:6,207,402...6,213,491
Ensembl chr16:6,207,402...6,213,392

G

G protein-coupled receptor 84

decreases expression

alpha phellandrene results in decreased expression of GPR84 mRNA

NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178

G

GREB1 like retinoic acid receptor coactivator

increases expression

alpha phellandrene results in increased expression of GREB1L mRNA

NCBI chr18:1,392,330...1,629,483
Ensembl chr18:1,392,725...1,628,067

G

glutamate ionotropic receptor NMDA type subunit associated protein 1

increases expression

alpha phellandrene results in increased expression of GRINA mRNA

NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366

G

glycosyltransferase-like domain containing 1

increases expression

alpha phellandrene results in increased expression of GTDC1 mRNA

NCBI chr 3:28,766,640...29,161,668
Ensembl chr 3:28,766,645...29,162,271

G

glycogen synthase 1

increases expression

alpha phellandrene results in increased expression of GYS1 mRNA

NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292

G

granzyme F

decreases expression

alpha phellandrene results in decreased expression of GZME mRNA

NCBI chr15:30,005,361...30,018,649
Ensembl chr15:30,007,267...30,018,649

G

H1.0 linker histone

increases expression

alpha phellandrene results in increased expression of H1F0 mRNA

NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694

G

H1.2 linker histone, cluster member

increases expression

alpha phellandrene results in increased expression of H1F2 mRNA

NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635

G

H2B clustered histone 18

increases expression

alpha phellandrene results in increased expression of H2BC18 mRNA

NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529

G

hydroxycarboxylic acid receptor 2

increases expression

alpha phellandrene results in increased expression of HCAR2 mRNA

NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504

G

HEAT repeat containing 1

decreases expression

alpha phellandrene results in decreased expression of HEATR1 mRNA

NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948

G

helicase with zinc finger 2

increases expression

alpha phellandrene results in increased expression of HELZ2 mRNA

NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159

G

HGH1 homolog

decreases expression

alpha phellandrene results in decreased expression of BRP16 mRNA

NCBI chr 7:108,091,918...108,094,740
Ensembl chr 7:108,091,951...108,094,737

G

hypoxia inducible lipid droplet-associated

increases expression

alpha phellandrene results in increased expression of HILPDA mRNA

NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557

G

HIVEP zinc finger 3

increases expression

alpha phellandrene results in increased expression of HIVEP3 mRNA

NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795

G

heat shock protein family A (Hsp70) member 2

increases expression

alpha phellandrene results in increased expression of HSPA2 mRNA

NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287

G

heat shock protein family A (Hsp70) member 5

decreases expression

alpha phellandrene results in decreased expression of HSPA5 mRNA

NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891

G

heat shock protein family A (Hsp70) member 8

decreases expression

alpha phellandrene results in decreased expression of HSPA8 mRNA

NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259

G

inhibitor of DNA binding 2

increases expression

alpha phellandrene results in increased expression of ID2 mRNA

NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

alpha phellandrene results in decreased expression of IDI1 mRNA

NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357

G

interferon induced with helicase C domain 1

increases expression

alpha phellandrene results in increased expression of IFIH1 mRNA

NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456

G

interferon, lambda 3

increases expression

alpha phellandrene results in increased expression of IFNL3 mRNA

NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096

G

interleukin 2 receptor subunit alpha

decreases expression

alpha phellandrene results in decreased expression of IL2RA mRNA

NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697

G

interleukin 36, gamma

decreases expression

alpha phellandrene results in decreased expression of IL36G mRNA

NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480

G

interferon regulatory factor 5

increases expression

alpha phellandrene results in increased expression of IRF5 mRNA

NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267

G

interferon regulatory factor 7

increases expression

alpha phellandrene results in increased expression of IRF7 mRNA

NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832

G

immunity-related GTPase M

increases expression

alpha phellandrene results in increased expression of IRGM2 mRNA

NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578

G

integrin subunit alpha L

increases expression

alpha phellandrene results in increased expression of ITGAL mRNA

NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732

G

jagunal homolog 1

decreases expression

alpha phellandrene results in decreased expression of JAGN1 mRNA

NCBI chr 4:146,591,577...146,596,287
Ensembl chr 4:146,591,510...146,596,288

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

alpha phellandrene results in increased expression of JUN mRNA

NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656

G

KN motif and ankyrin repeat domains 2

decreases expression

alpha phellandrene results in decreased expression of KANK2 mRNA

NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900

G

lysine demethylase 7A

increases expression

alpha phellandrene results in increased expression of KDM7A mRNA

NCBI chr 4:67,899,407...67,974,264
Ensembl chr 4:67,904,307...67,966,998

G

kelch-like family member 24

increases expression

alpha phellandrene results in increased expression of KLHL24 mRNA

NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636

G

LIM domain and actin binding 1

increases expression

alpha phellandrene results in increased expression of LIMA1 mRNA

NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473

G

LLGL scribble cell polarity complex component 2

decreases expression

alpha phellandrene results in decreased expression of LLGL2 mRNA

NCBI chr10:101,050,978...101,086,527
Ensembl chr10:101,051,408...101,086,525

G

small nucleolar RNA MBII-202

decreases expression

alpha phellandrene results in decreased expression of SNORD68 mRNA

NCBI chr19:51,154,626...51,154,708
Ensembl chr19:51,154,626...51,154,708

G

LIM domain containing preferred translocation partner in lipoma

increases expression

alpha phellandrene results in increased expression of LPP mRNA

NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597

G

listerin E3 ubiquitin protein ligase 1

decreases expression

alpha phellandrene results in decreased expression of LTN1 mRNA

NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886

G

lymphocyte antigen 6 family member H

decreases expression

alpha phellandrene results in decreased expression of LY6C1 mRNA; alpha phellandrene results in decreased expression of LY6C2 mRNA

NCBI chr 7:107,258,779...107,261,270
Ensembl chr 7:107,258,779...107,261,454

G

mitogen-activated protein kinase kinase 6

increases expression

alpha phellandrene results in increased expression of MAP2K6 mRNA

NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293

G

methionine adenosyltransferase 2A

decreases expression

alpha phellandrene results in decreased expression of MAT2A mRNA

NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493

G

mast cell-expressed membrane protein 1

increases expression

alpha phellandrene results in increased expression of MCEMP1 mRNA

NCBI chr12:1,721,781...1,727,350
Ensembl chr12:1,718,730...1,725,986

G

mediator of DNA damage checkpoint 1

increases expression

alpha phellandrene results in increased expression of MDC1 protein

NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240

G

midasin AAA ATPase 1

decreases expression

alpha phellandrene results in decreased expression of MDN1 mRNA

NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332

G

mediator complex subunit 29

decreases expression

alpha phellandrene results in decreased expression of MED29 mRNA

NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365

G

mediator complex subunit 31

increases expression

alpha phellandrene results in increased expression of MED31 mRNA

NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326

G

mitochondria-localized glutamic acid-rich protein

increases expression

alpha phellandrene results in increased expression of MGARP mRNA

NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612

G

alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase

decreases expression

alpha phellandrene results in decreased expression of MGAT2 mRNA

NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177

G

O-6-methylguanine-DNA methyltransferase

decreases expression

alpha phellandrene results in decreased expression of MGMT protein

NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756

G

MINDY lysine 48 deubiquitinase 2

increases expression

alpha phellandrene results in increased expression of MINDY2 mRNA

NCBI chr 8:71,268,274...71,327,698
Ensembl chr 8:71,256,447...71,328,453

G

microRNA 375

increases expression

alpha phellandrene results in increased expression of MIR375 mRNA

NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985

G

major histocompatibility complex, class I-related

increases expression

alpha phellandrene results in increased expression of MR1 mRNA

NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970

G

mitochondrial ribosomal protein L20

decreases expression

alpha phellandrene results in decreased expression of MRPL20 mRNA

NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492

G

mitochondrial ribosomal protein L45

increases expression

alpha phellandrene results in increased expression of MRPL45 mRNA

NCBI chr10:82,308,650...82,320,474
Ensembl chr10:82,308,427...82,320,474

G

MRT4 homolog, ribosome maturation factor

decreases expression

alpha phellandrene results in decreased expression of MRTO4 mRNA

NCBI chr 5:151,601,780...151,608,533
Ensembl chr 5:151,601,780...151,608,287

G

membrane spanning 4-domains A3

decreases expression

alpha phellandrene results in decreased expression of MS4A3 mRNA

NCBI chr 1:208,462,300...208,480,129
Ensembl chr 1:208,462,301...208,480,101

G

mechanistic target of rapamycin kinase

decreases expression

alpha phellandrene results in decreased expression of MTOR protein

NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311

G

metaxin 3

decreases expression

alpha phellandrene results in decreased expression of MTX3 mRNA

NCBI chr 2:24,066,332...24,079,708
Ensembl chr 2:24,066,365...24,079,670

G

mucin 13, cell surface associated

decreases expression

alpha phellandrene results in decreased expression of MUC13 mRNA

NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727

G

MX dynamin like GTPase 2

increases expression

alpha phellandrene results in increased expression of MX2 mRNA

NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342

G

max dimerization protein 1

increases expression

alpha phellandrene results in increased expression of MXD1 mRNA

NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751

G

myeloid-associated differentiation marker

increases expression

alpha phellandrene results in increased expression of MYADM mRNA

NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035

G

MYB binding protein 1a

decreases expression

alpha phellandrene results in decreased expression of MYBBP1A mRNA

NCBI chr10:57,056,897...57,067,258
Ensembl chr10:57,056,874...57,067,255

G

myosin IXA

increases expression

alpha phellandrene results in increased expression of MYO9A mRNA

NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514

G

nicotinamide phosphoribosyltransferase

increases expression

alpha phellandrene results in increased expression of NAMPT mRNA

NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100

G

N-acetyltransferase 10

decreases expression

alpha phellandrene results in decreased expression of NAT10 mRNA

NCBI chr 3:90,111,643...90,149,891
Ensembl chr 3:90,111,645...90,149,927

G

NDRG family member 2

increases expression

alpha phellandrene results in increased expression of NDRG2 mRNA

NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626

G

nuclear factor, interleukin 3 regulated

increases expression

alpha phellandrene results in increased expression of NFIL3 mRNA

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858

G

NFKB inhibitor alpha

increases expression

alpha phellandrene results in increased expression of NFKBIA mRNA

NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941

G

NHP2 ribonucleoprotein

decreases expression

alpha phellandrene results in decreased expression of NHP2 mRNA

NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545

G

nucleolar protein 10

decreases expression

alpha phellandrene results in decreased expression of NOL10 mRNA

NCBI chr 6:40,144,217...40,225,353
Ensembl chr 6:40,144,235...40,225,353

G

nucleolar protein 8

decreases expression

alpha phellandrene results in decreased expression of NOL8 mRNA

NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848

G

nucleolar and coiled-body phosphoprotein 1

decreases expression

alpha phellandrene results in decreased expression of NOLC1 mRNA

NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088

G

NOP2 nucleolar protein

decreases expression

alpha phellandrene results in decreased expression of NOP2 mRNA

NCBI chr 4:157,932,731...157,944,462
Ensembl chr 4:157,932,716...157,944,459

G

NOP56 ribonucleoprotein

decreases expression

alpha phellandrene results in decreased expression of NOP56 mRNA

NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841

G

nitric oxide synthase 2

increases expression

alpha phellandrene results in increased expression of NOS2 mRNA

NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210

G

nuclear transport factor 2-like export factor 2

increases expression

alpha phellandrene results in increased expression of NXT2 mRNA

NCBI chr X:105,855,616...105,862,902
Ensembl chr X:105,855,608...105,862,899

G

2'-5' oligoadenylate synthetase 1A

increases expression

alpha phellandrene results in increased expression of OAS1A mRNA; alpha phellandrene results in increased expression of OAS1B mRNA

NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517

G

2'-5'-oligoadenylate synthetase 3

increases expression

alpha phellandrene results in increased expression of OAS3 mRNA

NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781

G

oxysterol binding protein-like 9

increases expression

alpha phellandrene results in increased expression of OSBPL9 mRNA

NCBI chr 5:123,819,106...123,962,213
Ensembl chr 5:123,819,104...123,962,196

G

PABIR family member 2

increases expression

alpha phellandrene results in increased expression of PABIR2 mRNA

NCBI chr X:132,989,124...133,015,625
Ensembl chr X:132,989,124...133,015,580

G

poly (ADP-ribose) polymerase family, member 14

increases expression

alpha phellandrene results in increased expression of PARP14 mRNA

NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916

G

prenylcysteine oxidase 1 like

decreases expression

alpha phellandrene results in decreased expression of PCYOX1L mRNA

NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327

G

phosphodiesterase 3B

increases expression

alpha phellandrene results in increased expression of PDE3B mRNA

NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:168,607,022...168,769,334

G

phosphoethanolamine/phosphocholine phosphatase 1

increases expression

alpha phellandrene results in increased expression of PHOSPHO1 mRNA

NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342

G

phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta

increases expression

alpha phellandrene results in increased expression of PIK3CB mRNA

NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663

G

phospholipase D family, member 4

increases expression

alpha phellandrene results in increased expression of PLD4 mRNA

NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376

G

plexin domain containing 1

increases expression

alpha phellandrene results in increased expression of PLXDC1 mRNA

NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130

G

proline-rich nuclear receptor coactivator 2

increases expression

alpha phellandrene results in increased expression of PNRC2 mRNA

NCBI chr 5:148,103,966...148,106,950
Ensembl chr 5:148,095,699...148,107,242
Ensembl chr 5:148,095,699...148,107,242

G

RNA polymerase I subunit B

decreases expression

alpha phellandrene results in decreased expression of POLR1B mRNA

NCBI chr 3:116,333,910...116,358,385
Ensembl chr 3:116,333,889...116,358,379

G

POP1 homolog, ribonuclease P/MRP subunit

decreases expression

alpha phellandrene results in decreased expression of POP1 mRNA

NCBI chr 7:65,705,348...65,733,143
Ensembl chr 7:65,705,368...65,733,141

G

peter pan homolog

decreases expression

alpha phellandrene results in decreased expression of PPAN mRNA

NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938

G

phosphoribosyl pyrophosphate amidotransferase

decreases expression

alpha phellandrene results in decreased expression of PPAT mRNA

NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144

G

protein phosphatase, Mg2+/Mn2+ dependent, 1K

increases expression

alpha phellandrene results in increased expression of PPM1K mRNA

NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:87,612,204...87,636,152

G

protein phosphatase 2, regulatory subunit B', gamma

increases expression

alpha phellandrene results in increased expression of PPP2R5C mRNA

NCBI chr 6:129,461,689...129,598,344
Ensembl chr 6:129,461,648...129,598,346

G

PPARG related coactivator 1

decreases expression

alpha phellandrene results in decreased expression of PPRC1 mRNA

NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587

G

protein kinase, DNA-activated, catalytic subunit

decreases expression

alpha phellandrene results in decreased expression of PRKDC protein

NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952

G

serine protease 1

decreases expression

alpha phellandrene results in decreased expression of TRY10 mRNA

NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792

G

polypyrimidine tract binding protein 3

increases expression

alpha phellandrene results in increased expression of PTBP3 mRNA

NCBI chr 5:74,313,367...74,399,439
Ensembl chr 5:74,315,101...74,399,791

G

protein tyrosine phosphatase, mitochondrial 1

decreases expression

alpha phellandrene results in decreased expression of PTPMT1 mRNA

NCBI chr 3:76,889,922...76,899,427
Ensembl chr 3:76,889,922...76,899,427

G

protein tyrosine phosphatase, non-receptor type 7

decreases expression

alpha phellandrene results in decreased expression of PTPN7 mRNA

NCBI chr13:46,570,904...46,584,048
Ensembl chr13:46,571,712...46,583,308

G

pseudouridine synthase 7

decreases expression

alpha phellandrene results in decreased expression of PUS7 mRNA

NCBI chr 4:11,360,169...11,401,139
Ensembl chr 4:11,360,188...11,401,172

G

pseudouridine synthase 7 like

decreases expression

alpha phellandrene results in decreased expression of PUS7L mRNA

NCBI chr 7:125,659,507...125,706,582
Ensembl chr 7:125,659,507...125,682,333

G

RAD51 paralog C

increases expression

alpha phellandrene results in increased expression of RAD51C mRNA

NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,205,032...72,231,248

G

RAP2B, member of RAS oncogene family

increases expression

alpha phellandrene results in increased expression of RAP2B mRNA

NCBI chr 2:145,599,714...145,600,265
Ensembl chr 2:145,599,116...145,603,069

G

RNA binding motif protein 12B

decreases expression

alpha phellandrene results in decreased expression of RBM12B2 mRNA

NCBI chr 5:25,597,405...25,610,324
Ensembl chr 5:25,590,493...25,611,245

G

recombination signal binding protein for immunoglobulin kappa J region

increases expression

alpha phellandrene results in increased expression of RBPJ mRNA

NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353

G

RNA terminal phosphate cyclase-like 1

decreases expression

alpha phellandrene results in decreased expression of RCL1 mRNA

NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315

G

similar to RIKEN cDNA 3110043O21

increases expression

alpha phellandrene results in increased expression of C9ORF72 mRNA

NCBI chr 5:49,766,340...49,791,434
Ensembl chr 5:49,766,325...49,791,408

G

Rho-related BTB domain containing 2

increases expression

alpha phellandrene results in increased expression of RHOBTB2 mRNA

NCBI chr15:44,868,251...44,888,436
Ensembl chr15:44,870,376...44,888,651

G

RNA sensor RIG-1

increases expression

alpha phellandrene results in increased expression of RIGI mRNA

NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819

G

ring finger protein 141

increases expression

alpha phellandrene results in increased expression of RNF141 mRNA

NCBI chr 1:164,933,972...164,957,081
Ensembl chr 1:164,931,077...164,957,118

G

ring finger protein 19B

increases expression

alpha phellandrene results in increased expression of RNF19B mRNA

NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380

G

RP2 activator of ARL3 GTPase

increases expression

alpha phellandrene results in increased expression of RP2 mRNA

NCBI chr X:1,872,582...1,916,704
Ensembl chr X:1,873,306...1,916,688

G

ribonuclease P/MRP subunit p14

decreases expression

alpha phellandrene results in decreased expression of RPP14 mRNA

NCBI chr15:16,837,796...16,847,970
Ensembl chr15:16,836,859...16,852,101
Ensembl chr15:16,836,859...16,852,101

G

ribonuclease P/MRP subunit p38

decreases expression

alpha phellandrene results in decreased expression of RPP38 mRNA

NCBI chr17:74,914,066...74,917,742
Ensembl chr17:74,908,932...74,927,431

G

ribosomal protein S12

decreases expression

alpha phellandrene results in decreased expression of RPS12 mRNA

NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014

G

RAS related

increases expression

alpha phellandrene results in increased expression of RRAS mRNA

NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357

G

ribosomal RNA processing 12

decreases expression

alpha phellandrene results in decreased expression of RRP12 mRNA

NCBI chr 1:240,672,378...240,705,992
Ensembl chr 1:240,672,382...240,706,018

G

ribosomal RNA processing 15 homolog

decreases expression

alpha phellandrene results in decreased expression of RRP15 mRNA

NCBI chr13:98,276,276...98,299,357
Ensembl chr13:98,276,134...98,299,370

G

radical S-adenosyl methionine domain containing 2

increases expression

alpha phellandrene results in increased expression of RSAD2 mRNA

NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699

G

retrotransposon-like 1

decreases expression

alpha phellandrene results in decreased expression of RTL1 mRNA

NCBI chr 6:128,543,904...128,549,384
Ensembl chr 6:128,543,939...128,549,182

G

retrotransposon Gag like 8A

increases expression

alpha phellandrene results in increased expression of RTL8A mRNA

NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240

G

receptor (chemosensory) transporter protein 4

increases expression

alpha phellandrene results in increased expression of RTP4 mRNA

NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437

G

rubicon like autophagy enhancer

increases expression

alpha phellandrene results in increased expression of RUBCNL mRNA

NCBI chr15:50,332,458...50,377,494
Ensembl chr15:50,332,418...50,400,849

G

SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1

increases expression

alpha phellandrene results in increased expression of SAMHD1 mRNA

NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386

G

spermidine/spermine N1-acetyl transferase 1

increases expression

alpha phellandrene results in increased expression of SAT1 mRNA

NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813

G

SDA1 domain containing 1

decreases expression

alpha phellandrene results in decreased expression of SDAD1 mRNA

NCBI chr14:15,741,489...15,768,271
Ensembl chr14:15,741,434...15,771,066

G

SEC14-like lipid binding 1

increases expression

alpha phellandrene results in increased expression of SEC14L1 mRNA

NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068

G

selenium binding protein 1

increases expression

alpha phellandrene results in increased expression of SELENBP1 mRNA; alpha phellandrene results in increased expression of SELENBP2 mRNA

NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594

G

semaphorin 3C

decreases expression

alpha phellandrene results in decreased expression of SEMA3C mRNA

NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534

G

SUMO specific peptidase 2

decreases expression

alpha phellandrene results in decreased expression of SENP2 mRNA

NCBI chr11:78,981,429...79,018,274
Ensembl chr11:78,981,432...79,018,238

G

septin 8

increases expression

alpha phellandrene results in increased expression of SEPT8 mRNA

NCBI chr10:37,684,649...37,713,704
Ensembl chr10:37,684,639...37,713,174

G

SERTA domain containing 3

increases expression

alpha phellandrene results in increased expression of SERTAD3 mRNA

NCBI chr 1:82,763,535...82,767,271
Ensembl chr 1:82,763,149...82,769,001

G

Set nuclear proto-oncogene

decreases expression

alpha phellandrene results in decreased expression of SET mRNA

NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567

G

stratifin

increases expression

alpha phellandrene results in increased expression of SFN protein

NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314

G

SAGA complex associated factor 29

decreases expression

alpha phellandrene results in decreased expression of SGF29 mRNA

NCBI chr 1:181,238,458...181,271,931
Ensembl chr 1:181,238,468...181,274,781

G

shugoshin 2

increases expression

alpha phellandrene results in increased expression of SGO2A mRNA

NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229

G

sigma non-opioid intracellular receptor 1

decreases expression

alpha phellandrene results in decreased expression of SIGMAR1 mRNA

NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017

G

solute carrier family 1 member 5

decreases expression

alpha phellandrene results in decreased expression of SLC1A5 mRNA

NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952

G

solute carrier family 35, member B1

decreases expression

alpha phellandrene results in decreased expression of SLC35B1 mRNA

NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,327,945...80,335,274

G

solute carrier family 35 member D1

decreases expression

alpha phellandrene results in decreased expression of SLC35D1 mRNA

NCBI chr 5:117,928,628...117,981,289
Ensembl chr 5:117,934,352...117,981,311

G

solute carrier family 44 member 1

increases expression

alpha phellandrene results in increased expression of SLC44A1 mRNA

NCBI chr 5:68,061,941...68,241,912
Ensembl chr 5:68,063,618...68,241,909

G

solute carrier family 44, member 3

increases expression

alpha phellandrene results in increased expression of SLC44A3 mRNA

NCBI chr 2:209,552,138...209,628,182
Ensembl chr 2:209,552,144...209,629,044

G

solute carrier family 7 member 1

decreases expression

alpha phellandrene results in decreased expression of SLC7A1 mRNA

NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849

G

solute carrier family 7 member 11

decreases expression

alpha phellandrene results in decreased expression of SLC7A11 mRNA

NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536

G

solute carrier family 7 member 6

decreases expression

alpha phellandrene results in decreased expression of SLC7A6 mRNA

NCBI chr19:34,073,472...34,100,268
Ensembl chr19:34,074,286...34,100,268

G

schlafen family member 5

increases expression

alpha phellandrene results in increased expression of SLFN4 mRNA; alpha phellandrene results in increased expression of SLFN5 mRNA

NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109

G

small integral membrane protein 14

increases expression

alpha phellandrene results in increased expression of SMIM14 mRNA

NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760

G

spermine oxidase

increases expression

alpha phellandrene results in increased expression of SMOX mRNA

NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
Ensembl chr X:118,731,900...118,765,710

G

small nucleolar RNA, H/ACA box 20

decreases expression

alpha phellandrene results in decreased expression of SNORA20 mRNA

NCBI chr 1:47,830,540...47,830,669
Ensembl chr 8:71,142,787...71,142,916

G

small nucleolar RNA, H/ACA box 21

decreases expression

alpha phellandrene results in decreased expression of SNORA21 mRNA

NCBI chr10:82,775,114...82,775,249
Ensembl chr10:82,775,114...82,775,249

G

small nucleolar RNA, H/ACA box 26

decreases expression

alpha phellandrene results in decreased expression of SNORA26 mRNA

NCBI chr14:34,127,640...34,127,760
Ensembl chr14:34,127,640...34,127,760

G

small nucleolar RNA, H/ACA box 3A

decreases expression

alpha phellandrene results in decreased expression of SNORA3 mRNA

NCBI chr 1:163,540,664...163,540,793
Ensembl chr 1:163,540,664...163,540,793

G

small nucleolar RNA, H/ACA box 44

decreases expression

alpha phellandrene results in decreased expression of SNORA44 mRNA

NCBI chr 4:126,415,989...126,416,119
Ensembl chr 4:126,415,989...126,416,119

G

small nucleolar RNA, H/ACA box 61

decreases expression

alpha phellandrene results in decreased expression of SNORA61 mRNA

NCBI chr 5:144,506,420...144,506,549
Ensembl chr 5:144,506,420...144,506,549

G

small nucleolar RNA, H/ACA box 73b

decreases expression

alpha phellandrene results in decreased expression of SNORA73B mRNA

NCBI chr 5:144,545,179...144,545,382
Ensembl chr 5:144,545,179...144,545,382

G

small nucleolar RNA, H/ACA box 75

decreases expression

alpha phellandrene results in decreased expression of SNORA75 mRNA

NCBI chr 9:87,000,248...87,000,384
Ensembl chr 9:87,000,248...87,000,384

G

small nucleolar RNA, C/D box 22

decreases expression

alpha phellandrene results in decreased expression of SNORD22 mRNA

NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923

G

small nucleolar RNA, C/D box 34

decreases expression

alpha phellandrene results in decreased expression of SNORD34 mRNA

NCBI chr 8:115,045,817...115,045,883
Ensembl chr 8:115,045,817...115,045,883

G

small nucleolar RNA, C/D box 52

decreases expression

alpha phellandrene results in decreased expression of SNORD52 mRNA

NCBI chr20:3,878,412...3,878,477
Ensembl chr20:3,878,412...3,878,477

G

small nucleolar RNA, C/D box 82

decreases expression

alpha phellandrene results in decreased expression of SNORD82 mRNA

NCBI chr 9:87,004,515...87,004,586
Ensembl chr 9:87,004,515...87,004,586

G

small nucleolar RNA, C/D box 87

decreases expression

alpha phellandrene results in decreased expression of SNORD87 mRNA

NCBI chr 5:9,297,489...9,297,573
Ensembl chr 5:9,297,489...9,297,573

G

small nucleolar RNA, C/D box 95

decreases expression

alpha phellandrene results in decreased expression of SNORD95 mRNA

NCBI chr10:33,171,983...33,172,050
Ensembl chr10:33,171,983...33,172,050

G

small nucleolar RNA, C/D box 96A

decreases expression

alpha phellandrene results in decreased expression of SNORD96A mRNA

NCBI chr10:33,171,093...33,171,172
Ensembl chr10:33,171,093...33,171,172

G

small nuclear ribonucleoprotein D2 polypeptide

decreases expression

alpha phellandrene results in decreased expression of SNRPD2 mRNA

NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351
Ensembl chr20:78,798,377...78,803,351

G

SP100 nuclear antigen

increases expression

alpha phellandrene results in increased expression of SP100 mRNA

NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034

G

SP140 nuclear body protein

increases expression

alpha phellandrene results in increased expression of SP140 mRNA

NCBI chr 9:86,224,472...86,274,724
Ensembl chr 9:86,224,513...86,274,542

G

SPC25 component of NDC80 kinetochore complex

increases expression

alpha phellandrene results in increased expression of SPC25 mRNA

NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959

G

sprouty-related, EVH1 domain containing 3

increases expression

alpha phellandrene results in increased expression of SPRED3 mRNA

NCBI chr 1:84,458,779...84,470,425
Ensembl chr 1:84,459,314...84,470,249

G

sorcin

increases expression

alpha phellandrene results in increased expression of SRI mRNA

NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077

G

spermidine synthase

decreases expression

alpha phellandrene results in decreased expression of SRM mRNA

NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405

G

serine racemase

increases expression

alpha phellandrene results in increased expression of SRR mRNA

NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011

G

serine and arginine rich splicing factor 7

decreases expression

alpha phellandrene results in decreased expression of SRSF7 mRNA

NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965

G

signal sequence receptor subunit 4

decreases expression

alpha phellandrene results in decreased expression of SSR4 mRNA

NCBI chr X:151,524,191...151,528,218
Ensembl chr X:151,524,009...151,528,202

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5

decreases expression

alpha phellandrene results in decreased expression of ST8SIA5 mRNA

NCBI chr18:70,736,395...70,802,537
Ensembl chr18:70,736,602...70,797,789

G

STARD3 N-terminal like

increases expression

alpha phellandrene results in increased expression of STARD3NL mRNA

NCBI chr17:45,583,278...45,617,226
Ensembl chr17:45,583,266...45,617,226

G

StAR-related lipid transfer domain containing 5

increases expression

alpha phellandrene results in increased expression of STARD5 mRNA

NCBI chr 1:137,606,151...137,616,017
Ensembl chr 1:137,606,177...137,616,469

G

signal transducer and activator of transcription 1

increases expression

alpha phellandrene results in increased expression of STAT1 mRNA

NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540

G

signal transducer and activator of transcription 2

increases expression

alpha phellandrene results in increased expression of STAT2 mRNA

NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967

G

Suv3 like RNA helicase

decreases expression

alpha phellandrene results in decreased expression of SUPV3L1 mRNA

NCBI chr20:30,378,542...30,399,076
Ensembl chr20:30,378,550...30,399,054

G

TATA-box binding protein associated factor, RNA polymerase I subunit D

decreases expression

alpha phellandrene results in decreased expression of TAF1D mRNA

NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618

G

thromboxane A synthase 1

decreases expression

alpha phellandrene results in decreased expression of TBXAS1 mRNA

NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096

G

transcription elongation factor A N-terminal and central domain containing

increases expression

alpha phellandrene results in increased expression of TCEANC mRNA

NCBI chr X:27,952,539...27,961,038
Ensembl chr X:27,952,457...27,960,940

G

t-complex 11 like 2

increases expression

alpha phellandrene results in increased expression of TCP11L2 mRNA

NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095

G

tectonic family member 3

increases expression

alpha phellandrene results in increased expression of TCTN3 mRNA

NCBI chr 1:239,414,003...239,425,273
Ensembl chr 1:239,415,203...239,425,272

G

tudor domain containing 7

increases expression

alpha phellandrene results in increased expression of TDRD7 mRNA

NCBI chr 5:60,238,742...60,312,548
Ensembl chr 5:60,238,678...60,312,544

G

TEPSIN, adaptor related protein complex 4 accessory protein

decreases expression

alpha phellandrene results in decreased expression of TEPSIN mRNA

NCBI chr10:105,373,939...105,381,310
Ensembl chr10:105,373,941...105,382,266

G

testis associated actin remodelling kinase 2

increases expression

alpha phellandrene results in increased expression of TESK2 mRNA

NCBI chr 5:130,178,715...130,270,594
Ensembl chr 5:130,185,033...130,271,292

G

transcription factor AP-4

decreases expression

alpha phellandrene results in decreased expression of TFAP4 mRNA

NCBI chr10:11,001,338...11,019,386
Ensembl chr10:11,002,911...11,019,386

G

tRNA-histidine guanylyltransferase 1-like

decreases expression

alpha phellandrene results in decreased expression of THG1L mRNA

NCBI chr10:30,387,929...30,396,579
Ensembl chr10:30,387,940...30,396,687

G

translocase of inner mitochondrial membrane 10

decreases expression

alpha phellandrene results in decreased expression of TIMM10 mRNA

NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940

G

transmembrane protein 120A

decreases expression

alpha phellandrene results in decreased expression of TMEM120A mRNA

NCBI chr12:20,942,243...20,950,908
Ensembl chr12:20,942,439...20,990,316

G

transmembrane protein 97

decreases expression

alpha phellandrene results in decreased expression of TMEM97 mRNA

NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730

G

thymosin, beta 10

increases expression

alpha phellandrene results in increased expression of TMSB10 mRNA

NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028

G

thymosin beta 4, X-linked

increases expression

alpha phellandrene results in increased expression of TMSB4X mRNA

NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667
Ensembl chr10:27,128,610...27,146,667

G

tumor protein p53

decreases expression
increases phosphorylation
affects localization
increases expression

alpha phellandrene results in decreased expression of TRP53 protein
alpha phellandrene results in increased phosphorylation of TRP53 protein
alpha phellandrene affects the localization of TP53 protein
alpha phellandrene results in increased expression of TRP53 protein modified form

PMID:24861204 PMID:25649747

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

tumor protein D52

increases expression

alpha phellandrene results in increased expression of TPD52 mRNA

NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622

G

tropomyosin 4

increases expression

alpha phellandrene results in increased expression of TPM4 mRNA

NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984

G

tripartite motif-containing 21

increases expression

alpha phellandrene results in increased expression of TRIM21 mRNA

NCBI chr 1:156,964,896...156,987,504
Ensembl chr 1:156,964,913...156,987,440

G

TSPO associated protein 1

increases expression

alpha phellandrene results in increased expression of TSPOAP1 mRNA

NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412

G

TSR1, ribosome maturation factor

decreases expression

alpha phellandrene results in decreased expression of TSR1 mRNA

NCBI chr10:59,760,420...59,771,868
Ensembl chr10:59,760,409...59,771,864

G

thiosulfate sulfurtransferase like domain containing 3

increases expression

alpha phellandrene results in increased expression of TSTD3 mRNA

NCBI chr 5:35,294,652...35,304,093
Ensembl chr 5:35,294,645...35,304,101

G

tetratricopeptide repeat domain 27

decreases expression

alpha phellandrene results in decreased expression of TTC27 mRNA

NCBI chr 6:20,558,756...20,702,126
Ensembl chr 6:20,558,756...20,702,115

G

ubiquitin associated and SH3 domain containing, A

decreases expression

alpha phellandrene results in decreased expression of UBASH3A mRNA

NCBI chr20:9,291,471...9,334,685
Ensembl chr20:9,292,139...9,329,224

G

ubiquitin-conjugating enzyme E2H

increases expression

alpha phellandrene results in increased expression of UBE2H mRNA

NCBI chr 4:58,834,674...58,930,156
Ensembl chr 4:58,834,674...58,930,156

G

URB2 ribosome biogenesis homolog

decreases expression

alpha phellandrene results in decreased expression of URB2 mRNA

NCBI chr19:52,011,019...52,036,607
Ensembl chr19:52,011,112...52,036,597

G

ubiquitin specific peptidase 18

increases expression

alpha phellandrene results in increased expression of USP18 mRNA

NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144

G

ubiquitin specific peptidase 22

increases expression

alpha phellandrene results in increased expression of USP22 mRNA

NCBI chr10:45,828,619...45,855,468
Ensembl chr10:45,828,622...45,855,497

G

ubiquitin specific peptidase 36

decreases expression

alpha phellandrene results in decreased expression of USP36 mRNA

NCBI chr10:103,497,349...103,528,877
Ensembl chr10:103,497,349...103,528,877

G

UTP20 small subunit processome component

decreases expression

alpha phellandrene results in decreased expression of UTP20 mRNA

NCBI chr 7:23,134,630...23,215,639
Ensembl chr 7:23,134,637...23,215,632

G

WD repeat domain 12

decreases expression

alpha phellandrene results in decreased expression of WDR12 mRNA

NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469

G

WD repeat domain 3

decreases expression

alpha phellandrene results in decreased expression of WDR3 mRNA

NCBI chr 2:187,505,816...187,528,432
Ensembl chr 2:187,505,816...187,528,432

G

WD repeat domain 74

decreases expression

alpha phellandrene results in decreased expression of WDR74 mRNA

NCBI chr 1:205,631,769...205,636,558
Ensembl chr 1:205,631,824...205,636,563

G

WD repeat domain 75

decreases expression

alpha phellandrene results in decreased expression of WDR75 mRNA

NCBI chr 9:47,903,214...47,933,399
Ensembl chr 9:47,903,200...47,933,399

G

WD repeat, sterile alpha motif and U-box domain containing 1

increases expression

alpha phellandrene results in increased expression of WDSUB1 mRNA

NCBI chr 3:44,340,415...44,370,890
Ensembl chr 3:44,340,415...44,370,891

G

WD repeat domain, phosphoinositide interacting 1

increases expression

alpha phellandrene results in increased expression of WIPI1 mRNA

NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846

G

XIAP associated factor 1

increases expression

alpha phellandrene results in increased expression of XAF1 mRNA

NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770

G

tyrosyl-tRNA synthetase 2

decreases expression

alpha phellandrene results in decreased expression of YARS2 mRNA

NCBI chr11:84,632,350...84,638,138
Ensembl chr11:84,624,369...84,638,125

G

Z-DNA binding protein 1

increases expression

alpha phellandrene results in increased expression of ZBP1 mRNA

NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870

G

zinc finger protein 26

decreases expression

alpha phellandrene results in decreased expression of ZFP882 mRNA

NCBI chr 8:18,959,656...18,985,647
Ensembl chr 8:18,965,271...18,988,325

G

zinc finger protein 260

increases expression

alpha phellandrene results in increased expression of ZFP260 mRNA

NCBI chr 1:85,336,567...85,349,896
Ensembl chr 1:85,336,618...85,350,067

G

zinc finger protein 346

decreases expression

alpha phellandrene results in decreased expression of ZFP346 mRNA

NCBI chr17:9,493,787...9,523,681
Ensembl chr17:9,493,803...9,523,635

(S)-(-)-perillyl alcohol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BCL2-antagonist/killer 1

increases expression

perillyl alcohol results in increased expression of BAK1 protein

NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264

G

BCL2 associated X, apoptosis regulator

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of BAX protein]

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

BCL2, apoptosis regulator

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein]

NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

catalase

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased activity of CAT protein]
perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of CAT protein]

PMID:19161993 PMID:20923693

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

cyclin A2

decreases expression

perillyl alcohol results in decreased expression of CCNA2 protein

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

cyclin B1

decreases expression

perillyl alcohol results in decreased expression of CCNB1 protein

NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172

G

cyclin dependent kinase 2

decreases expression
multiple interactions

perillyl alcohol results in decreased expression of CDK2 protein
perillyl alcohol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]; perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]

NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403

G

cyclin-dependent kinase inhibitor 1A

increases response to substance
multiple interactions
increases expression

CDKN1A protein results in increased susceptibility to perillyl alcohol
perillyl alcohol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]
perillyl alcohol results in increased expression of CDKN1A protein

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 1B

increases expression
increases response to substance
multiple interactions

perillyl alcohol results in increased expression of CDKN1B protein
CDKN1B protein results in increased susceptibility to perillyl alcohol
perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]

NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982

G

F-box protein 32

increases expression

perillyl alcohol results in increased expression of FBXO32 mRNA; perillyl alcohol results in increased expression of FBXO32 protein

NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436

G

farnesyltransferase, CAAX box, subunit alpha

multiple interactions

[Vitamin A co-treated with perillyl alcohol] results in decreased expression of FNTA protein

NCBI chr16:66,065,131...66,083,460
Ensembl chr16:66,065,132...66,083,460

G

farnesyltransferase, CAAX box, subunit beta

multiple interactions
increases expression
decreases expression

[perillyl alcohol co-treated with Vitamin A] results in decreased expression of FNTB mRNA
perillyl alcohol results in increased expression of FNTB protein
perillyl alcohol results in decreased expression of FNTB mRNA

NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586

G

glutathione-disulfide reductase

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GSR protein]
perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of GSR protein]

PMID:19161993 PMID:20923693

NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661

G

hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)

multiple interactions

perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of H6PD protein]

NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171

G

involucrin

decreases expression

perillyl alcohol results in decreased expression of IVL protein

NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100

G

mitogen activated protein kinase 1

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]

NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616

G

mitogen activated protein kinase 3

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]

NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863

G

ornithine decarboxylase 1

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein]

NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440

G

Raf-1 proto-oncogene, serine/threonine kinase

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RAF1 protein]

NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317

G

RAP1A, member of RAS oncogene family

multiple interactions
increases expression

Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RAP1A protein]

NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

perillyl alcohol inhibits the reaction [Ethanol results in increased activity of RELA protein]

NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484

G

ras homolog family member A

multiple interactions
increases expression

Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RHOA protein]
[perillyl alcohol co-treated with Vitamin A] results in increased expression of RHOA mRNA

PMID:12671036 PMID:15959631

NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746

G

ras homolog family member B

multiple interactions
increases expression

Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RHOB protein]
perillyl alcohol results in increased expression of RHOB mRNA; perillyl alcohol results in increased expression of RHOB protein
[perillyl alcohol co-treated with Vitamin A] affects the expression of RHOB mRNA; [perillyl alcohol co-treated with Vitamin A] affects the expression of RHOB protein

PMID:12671036 PMID:15959631

NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108

G

tumor necrosis factor

multiple interactions

perillyl alcohol inhibits the reaction [Ethanol results in increased expression of TNF protein]

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

1,8-cineole

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acetyl-CoA carboxylase alpha

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACACA mRNA

NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457

G

acetyl-CoA carboxylase beta

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ACACB mRNA

NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655

G

ATP citrate lyase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA

NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320

G

actin alpha 2, smooth muscle

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACTA2 mRNA

NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554

G

actin related protein 2

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of ACTR2 protein]

NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524

G

aryl hydrocarbon receptor

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of AHR mRNA

NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568

G

AKT serine/threonine kinase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of AKT1 mRNA

NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921

G

ankyrin repeat domain 17

decreases expression

Eucalyptol results in decreased expression of ANKRD17 mRNA

NCBI chr14:17,723,239...17,861,841
Ensembl chr14:17,721,932...17,862,617

G

APC regulator of WNT signaling pathway

increases expression

Eucalyptol results in increased expression of APC mRNA

NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696

G

achaete-scute family bHLH transcription factor 1

decreases expression

Eucalyptol results in decreased expression of ASCL1 mRNA

NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993

G

BCL2-associated agonist of cell death

increases expression

Eucalyptol results in increased expression of BAD mRNA

NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823

G

catalase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of CAT mRNA

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

cellular communication network factor 2

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of CTGF mRNA

NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734

G

cell division cycle 42

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of CDC42 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of CDC42 protein]

NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

decreases expression

Eucalyptol results in decreased expression of CITED2 mRNA

NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897

G

collagen type I alpha 1 chain

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of COL1A1 mRNA

NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624

G

carnitine palmitoyltransferase 1A

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of CPT1A mRNA

NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055

G

carnitine palmitoyltransferase 2

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of CPT2 mRNA

NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095

G

cathepsin D

multiple interactions
increases expression

Fulvestrant inhibits the reaction [Eucalyptol results in increased expression of CTSD mRNA]

NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488

G

cortactin

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of CTTN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of CTTN protein]

NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of CYP1A1 mRNA

NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125

G

cytochrome P450, family 2, subfamily b, polypeptide 3

multiple interactions

Eucalyptol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion]

NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143

G

cytochrome P450, family 3, subfamily a, polypeptide 2

increases hydroxylation
multiple interactions

CYP3A4 protein results in increased hydroxylation of Eucalyptol
Eucalyptol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]

PMID:15715982 PMID:18385293

NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008

G

cytochrome P450, family 3, subfamily a, polypeptide 9

increases hydroxylation

CYP3A5 protein results in increased hydroxylation of Eucalyptol

NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422

G

diacylglycerol O-acyltransferase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of DGAT1 mRNA

NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299

G

ezrin

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of EZR protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of EZR protein]

NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505

G

fatty acid synthase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of FASN mRNA

NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261

G

forkhead box O1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of FOXO1 mRNA

NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790

G

glutathione peroxidase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of GPX1 mRNA

NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024

G

growth regulating estrogen receptor binding 1

multiple interactions
increases expression

Fulvestrant inhibits the reaction [Eucalyptol results in increased expression of GREB1 mRNA]

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

glycogen synthase kinase 3 beta

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]

NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646

G

glutathione-disulfide reductase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of GSR mRNA

NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661

G

3-hydroxy-3-methylglutaryl-CoA reductase

decreases expression

Eucalyptol results in decreased expression of HMGCR protein

NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703

G

intercellular adhesion molecule 1

multiple interactions

Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ICAM1 mRNA]; Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ICAM1 protein]

NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438

G

interleukin 1 beta

multiple interactions

[Ibuprofen co-treated with Eucalyptol] inhibits the reaction [ammonium acetate results in increased expression of IL1B mRNA]; Eucalyptol inhibits the reaction [ammonium acetate results in increased expression of IL1B mRNA]

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 6

multiple interactions

[Ibuprofen co-treated with Eucalyptol] inhibits the reaction [ammonium acetate results in increased expression of IL6 mRNA]; Eucalyptol inhibits the reaction [ammonium acetate results in increased expression of IL6 mRNA]; Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 protein]

PMID:29789401 PMID:36346500

NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178

G

lymphoid enhancer binding factor 1

decreases expression

Eucalyptol results in decreased expression of LEF1 mRNA

NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794

G

leptin

multiple interactions

Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of CTTN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of EZR protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PTK2 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of SRC protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of SYNPO protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of TLN1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of VCL protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased abundance of Blood Glucose]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of CDC42 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of PXN protein modified form]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of RAC1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of RHOA protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of ROCK1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of VCL protein modified form]

NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262

G

mitogen-activated protein kinase 8

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased phosphorylation of MAPK8 protein]

NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981

G

mitogen-activated protein kinase 9

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased phosphorylation of MAPK9 protein]

NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178

G

malonyl-CoA decarboxylase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of MLYCD mRNA

NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793

G

mucin 19, oligomeric

decreases expression

Eucalyptol results in decreased expression of MUC19 mRNA

NCBI chr 7:123,017,896...123,139,053
Ensembl chr 7:123,017,896...123,139,053

G

mucin 2, oligomeric mucus/gel-forming

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides results in increased expression of MUC2 mRNA]

NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756

G

mucin 5AC, oligomeric mucus/gel-forming

multiple interactions

Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MUC5AC mRNA]; Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MUC5AC protein]

NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475

G

MYC proto-oncogene, bHLH transcription factor

decreases expression

Eucalyptol results in decreased expression of MYC mRNA

NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630

G

NFE2 like bZIP transcription factor 2

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA

NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737

G

nuclear factor kappa B subunit 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFKB1 mRNA

NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404

G

NFKB inhibitor alpha

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides affects the expression of NFKBIA protein]; Eucalyptol inhibits the reaction [Lipopolysaccharides inhibits the reaction [RELA protein binds to NFKBIA protein]]

NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941

G

nuclear receptor subfamily 4, group A, member 3

decreases expression

Eucalyptol results in decreased expression of NR4A3 mRNA

NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733

G

platelet derived growth factor receptor beta

decreases expression

Eucalyptol results in decreased expression of PDGFRB mRNA

NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843

G

peroxisome proliferator activated receptor alpha

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of PPARA mRNA

NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346

G

prostaglandin-endoperoxide synthase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of PTGS1 mRNA

NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586

G

protein tyrosine kinase 2

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of PTK2 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PTK2 protein]

NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783

G

protein tyrosine kinase 6

decreases expression

Eucalyptol results in decreased expression of PTK6 mRNA

NCBI chr 3:168,307,073...168,315,664
Ensembl chr 3:168,307,073...168,315,664

G

paxillin

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of PXN protein modified form]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]

NCBI chr12:41,060,791...41,107,952
Ensembl chr12:41,060,791...41,107,931

G

Rac family small GTPase 1

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of RAC1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of RAC1 protein]

NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides inhibits the reaction [RELA protein binds to NFKBIA protein]]

NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484

G

ras homolog family member A

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of RHOA protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of RHOA protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]]

NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746

G

Rho-associated coiled-coil containing protein kinase 1

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of ROCK1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of ROCK1 protein]

NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571

G

SEC14-like lipid binding 2

multiple interactions

Eucalyptol inhibits the reaction [Testosterone results in increased expression of SEC14L2 mRNA]

NCBI chr14:78,973,805...78,998,480
Ensembl chr14:78,973,808...78,993,788

G

snail family transcriptional repressor 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of SNAI1 mRNA

NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969

G

superoxide dismutase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of SOD1 mRNA

NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249

G

SRC proto-oncogene, non-receptor tyrosine kinase

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of SRC protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of SRC protein]

NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476

G

synaptopodin

multiple interactions

Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of SYNPO protein]

NCBI chr18:54,048,299...54,106,388
Ensembl chr18:54,026,152...54,102,126

G

T-box transcription factor 3

affects expression

Eucalyptol affects the expression of TBX3 mRNA

NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708

G

transforming growth factor, beta 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of TGFB1 mRNA

NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847

G

transglutaminase 1

decreases expression

Eucalyptol results in decreased expression of TGM1 mRNA

NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523

G

talin 1

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of TLN1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of TLN1 protein]

NCBI chr 5:57,787,670...57,817,900
Ensembl chr 5:57,787,943...57,817,900

G

tumor necrosis factor

multiple interactions

Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TNF protein]
Eucalyptol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]

PMID:23872422 PMID:26207629 PMID:29789401

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

G

tripartite motif-containing 21

decreases expression

Eucalyptol results in decreased expression of TRIM21 mRNA

NCBI chr 1:156,964,896...156,987,504
Ensembl chr 1:156,964,913...156,987,440

G

vinculin

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of VCL protein modified form]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of VCL protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of VCL protein modified form]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]]

NCBI chr15:3,265,776...3,355,586
Ensembl chr15:3,265,815...3,355,606

G

zinc finger E-box binding homeobox 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA

NCBI chr17:51,948,948...52,116,018
Ensembl chr17:51,948,948...52,115,214

G

zinc finger E-box binding homeobox 2

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB2 mRNA

NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157

4-terpineol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cathepsin D

increases expression
multiple interactions

terpinenol-4 results in increased expression of CTSD mRNA
Fulvestrant inhibits the reaction [terpinenol-4 results in increased expression of CTSD mRNA]

NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488

G

cytochrome P450, family 4, subfamily f, polypeptide 6

multiple interactions

terpinenol-4 inhibits the reaction [Testosterone results in increased expression of CYP4F8 mRNA]

NCBI chr 7:12,030,276...12,058,020
Ensembl chr 7:12,030,301...12,057,782

G

estrogen receptor 1

increases activity
multiple interactions

terpinenol-4 results in increased activity of ESR1 protein
NCOA2 protein promotes the reaction [terpinenol-4 results in increased activity of ESR1 protein]

NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002

G

growth regulating estrogen receptor binding 1

increases expression
multiple interactions

terpinenol-4 results in increased expression of GREB1 mRNA
Fulvestrant inhibits the reaction [terpinenol-4 results in increased expression of GREB1 mRNA]

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

nuclear receptor coactivator 2

multiple interactions

NCOA2 protein promotes the reaction [terpinenol-4 results in increased activity of ESR1 protein]

NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451

G

progesterone receptor

multiple interactions
increases expression

Fulvestrant inhibits the reaction [terpinenol-4 results in increased expression of PGR mRNA]

NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344

G

SEC14-like lipid binding 2

multiple interactions

terpinenol-4 inhibits the reaction [Testosterone results in increased expression of SEC14L2 mRNA]

NCBI chr14:78,973,805...78,998,480
Ensembl chr14:78,973,808...78,993,788

G

UDP glucuronosyltransferase family 2 member B15

increases metabolic processing

UGT2B15 protein results in increased metabolism of terpinenol-4

NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589

G

UDP glucuronosyltransferase 2 family, polypeptide B34 like 1

multiple interactions

terpinenol-4 inhibits the reaction [Testosterone results in increased expression of UGT2B28 mRNA]

NCBI chr14:21,146,140...21,167,706
Ensembl chr14:21,145,827...21,167,704

alpha-phellandrene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

apoptosis antagonizing transcription factor

decreases expression

alpha phellandrene results in decreased expression of AATF mRNA

NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201

G

acid phosphatase 1

decreases expression

alpha phellandrene results in decreased expression of ACP1 mRNA

NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021

G

acyl-CoA synthetase short-chain family member 2

increases expression

alpha phellandrene results in increased expression of ACSS2 mRNA

NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675

G

ADAM metallopeptidase domain 18

decreases expression

alpha phellandrene results in decreased expression of ADAM18 mRNA

NCBI chr16:67,352,360...67,425,820
Ensembl chr16:67,352,416...67,425,248

G

ADAM metallopeptidase domain 3A

decreases expression

alpha phellandrene results in decreased expression of ADAM3 mRNA

NCBI chr16:67,299,949...67,349,970
Ensembl chr16:67,299,949...67,349,968

G

AFG2 AAA ATPase homolog A

decreases expression

alpha phellandrene results in decreased expression of AFG2A mRNA

NCBI chr 2:120,306,417...120,497,707
Ensembl chr 2:120,306,412...120,497,705

G

AKT serine/threonine kinase 1

decreases expression

alpha phellandrene results in decreased expression of AKT1 protein

NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921

G

aldehyde dehydrogenase 1 family, member L2

increases expression

alpha phellandrene results in increased expression of ALDH1L2 mRNA

NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776

G

aldolase, fructose-bisphosphate C

increases expression

alpha phellandrene results in increased expression of ALDOC mRNA

NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066

G

ankyrin repeat domain 49

decreases expression

alpha phellandrene results in decreased expression of ANKRD49 mRNA

NCBI chr 8:11,627,512...11,632,200
Ensembl chr 8:11,627,518...11,632,207

G

annexin A1

increases expression

alpha phellandrene results in increased expression of ANXA1 mRNA

NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343

G

annexin A9

decreases expression

alpha phellandrene results in decreased expression of ANXA9 mRNA

NCBI chr 2:182,873,185...182,884,501
Ensembl chr 2:182,872,929...182,883,374

G

adaptor related protein complex 3 subunit mu 2

increases expression

alpha phellandrene results in increased expression of AP3M2 mRNA

NCBI chr16:69,217,526...69,237,372
Ensembl chr16:69,217,633...69,235,431

G

arginase 2

increases expression

alpha phellandrene results in increased expression of ARG2 mRNA

NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378

G

Rho guanine nucleotide exchange factor 12

increases expression

alpha phellandrene results in increased expression of ARHGEF12 mRNA

NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366

G

arylsulfatase family, member K

decreases expression

alpha phellandrene results in decreased expression of ARSK mRNA

NCBI chr 2:5,574,319...5,631,451
Ensembl chr 2:5,574,322...5,631,467

G

aspartoacylase

increases expression

alpha phellandrene results in increased expression of ASPA mRNA

NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272

G

activating transcription factor 3

increases expression

alpha phellandrene results in increased expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

BCL2, apoptosis regulator

increases phosphorylation

alpha phellandrene results in increased phosphorylation of BCL2 protein

NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

beclin 1

increases phosphorylation

alpha phellandrene results in increased phosphorylation of BECN1 protein

NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742

G

Bcl2 modifying factor

increases expression

alpha phellandrene results in increased expression of BMF mRNA

NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145

G

BCL2 interacting protein 3

increases expression

alpha phellandrene results in increased expression of BNIP3 mRNA

NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359

G

biorientation of chromosomes in cell division 1

increases expression

alpha phellandrene results in increased expression of BOD1 mRNA

NCBI chr10:15,993,454...15,999,795
Ensembl chr10:15,993,454...15,999,787

G

BRCA1, DNA repair associated

decreases expression

alpha phellandrene results in decreased expression of BRCA1 protein

NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304

G

BTG anti-proliferation factor 2

increases expression

alpha phellandrene results in increased expression of BTG2 mRNA

NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628

G

calmodulin 2

increases expression

alpha phellandrene results in increased expression of CALM2 mRNA

NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
Ensembl chr15:7,091,567...7,104,287

G

calpain, small subunit 1

increases expression

alpha phellandrene results in increased expression of CAPNS1 mRNA

NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795

G

caprin family member 2

increases expression

alpha phellandrene results in increased expression of CAPRIN2 mRNA

NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830

G

caspase recruitment domain family, member 6

increases expression

alpha phellandrene results in increased expression of CARD6 mRNA

NCBI chr 2:54,194,343...54,206,902
Ensembl chr 2:54,195,739...54,206,846

G

calcium regulated heat stable protein 1

increases expression

alpha phellandrene results in increased expression of CARHSP1 mRNA

NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019

G

C-C motif chemokine ligand 5

increases expression

alpha phellandrene results in increased expression of CCL5 mRNA

NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377

G

cyclin G2

increases expression

alpha phellandrene results in increased expression of CCNG2 mRNA

NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830

G

C-C motif chemokine receptor like 2

increases expression

alpha phellandrene results in increased expression of CCRL2 mRNA

NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664

G

CD59b molecule

decreases expression

alpha phellandrene results in decreased expression of CD59A mRNA

NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847

G

CUB domain containing protein 2

increases expression

alpha phellandrene results in increased expression of CDCP2 mRNA

NCBI chr 5:121,877,581...121,894,203
Ensembl chr 5:121,877,581...121,894,203

G

cyclin-dependent kinase inhibitor 1A

increases expression

alpha phellandrene results in increased expression of CDKN1A mRNA

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin dependent kinase inhibitor 2D

increases expression

alpha phellandrene results in increased expression of CDKN2D mRNA

NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674

G

CASP8 and FADD-like apoptosis regulator

increases expression

alpha phellandrene results in increased expression of CFLAR mRNA

NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034

G

C-type lectin domain family 12, member A

decreases expression

alpha phellandrene results in decreased expression of CLEC12A mRNA

NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753

G

C-type lectin domain family 4, member D

decreases expression

alpha phellandrene results in decreased expression of CLEC4D mRNA

NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848

G

C-type lectin domain family 6, member A, pseudogene 1

decreases expression

alpha phellandrene results in decreased expression of CLEC4N mRNA

NCBI chr 4:156,539,408...156,559,032
Ensembl chr 4:156,539,408...156,558,605
Ensembl chr 4:156,539,408...156,558,605

G

clustered mitochondria homolog

decreases expression

alpha phellandrene results in decreased expression of CLUH mRNA

NCBI chr10:59,509,580...59,531,345
Ensembl chr10:59,509,726...59,531,345

G

cytidine/uridine monophosphate kinase 2

increases expression

alpha phellandrene results in increased expression of CMPK2 mRNA

NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183

G

complement C3b/C4b receptor 1 like

decreases expression

alpha phellandrene results in decreased expression of CR1L mRNA

NCBI chr13:106,606,952...106,660,442
Ensembl chr13:106,574,858...106,660,445

G

cysteine-rich secretory protein 1

decreases expression

alpha phellandrene results in decreased expression of CRISP1 mRNA

NCBI chr 9:20,741,775...20,768,796
Ensembl chr 9:20,741,777...20,768,796

G

cystatin F

decreases expression

alpha phellandrene results in decreased expression of CST7 mRNA

NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557

G

cystatin A

increases expression

alpha phellandrene results in increased expression of STFA1 mRNA

NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488

G

cathepsin G

decreases expression

alpha phellandrene results in decreased expression of CTSG mRNA

NCBI chr15:29,930,988...29,937,353
Ensembl chr15:29,931,003...29,937,353

G

C-X-C motif chemokine ligand 10

increases expression

alpha phellandrene results in increased expression of CXCL10 mRNA

NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975

G

cytochrome b561 family, member D2

decreases expression

alpha phellandrene results in decreased expression of CYB561D2 mRNA

NCBI chr 8:108,213,201...108,215,778
Ensembl chr 8:108,213,205...108,215,759

G

cytoplasmic FMR1 interacting protein 2

increases expression

alpha phellandrene results in increased expression of CYFIP2 mRNA

NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113

G

cytochrome P450, family 51

decreases expression

alpha phellandrene results in decreased expression of CYP51 mRNA

NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
Ensembl chr 6:30,036,865...30,055,410

G

developing brain homeobox 1

increases expression

alpha phellandrene results in increased expression of DBX1 mRNA

NCBI chr 1:99,348,638...99,354,173
Ensembl chr 1:99,349,608...99,354,038

G

dCMP deaminase

decreases expression

alpha phellandrene results in decreased expression of DCTD mRNA

NCBI chr16:44,066,952...44,098,654
Ensembl chr16:44,055,128...44,098,446

G

DNA-damage-inducible transcript 4

increases expression

alpha phellandrene results in increased expression of DDIT4 mRNA

NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105

G

DEAD-box helicase 31

decreases expression

alpha phellandrene results in decreased expression of DDX31 mRNA

NCBI chr 3:12,172,829...12,238,392
Ensembl chr 3:12,172,836...12,238,873

G

DEXD/H-box helicase 60

increases expression

alpha phellandrene results in increased expression of DDX60 mRNA

NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526

G

DNA fragmentation factor subunit beta

increases expression

alpha phellandrene results in increased expression of DFFB mRNA

NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628

G

diacylglycerol kinase, alpha

increases expression

alpha phellandrene results in increased expression of DGKA mRNA

NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110

G

dehydrogenase/reductase 1

increases expression

alpha phellandrene results in increased expression of DHRS1 mRNA

NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838

G

DEAH-box helicase 33

decreases expression

alpha phellandrene results in decreased expression of DHX33 mRNA

NCBI chr10:55,708,102...55,724,618
Ensembl chr10:55,705,756...55,724,567

G

DEXH-box helicase 58

increases expression

alpha phellandrene results in increased expression of DHX58 mRNA

NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525

G

dyskerin pseudouridine synthase 1

decreases expression

alpha phellandrene results in decreased expression of DKC1 mRNA

G

dual specificity phosphatase 1

increases expression

alpha phellandrene results in increased expression of DUSP1 mRNA

NCBI chr10:16,680,478...16,683,275

G

dual specificity phosphatase 6

increases expression

alpha phellandrene results in increased expression of DUSP6 mRNA

NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185

G

dynein light chain Tctex-type 3

increases expression

alpha phellandrene results in increased expression of DYNLT3 mRNA

NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139

G

egl-9 family hypoxia-inducible factor 3

increases expression

alpha phellandrene results in increased expression of EGLN3 mRNA

NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766

G

early growth response 1

increases expression

alpha phellandrene results in increased expression of EGR1 mRNA

NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766

G

eukaryotic translation initiation factor 5

decreases expression

alpha phellandrene results in decreased expression of EIF5 mRNA

NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656

G

elaC ribonuclease Z 2

decreases expression

alpha phellandrene results in decreased expression of ELAC2 mRNA

NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614

G

ELOVL fatty acid elongase 1

decreases expression

alpha phellandrene results in decreased expression of ELOVL1 mRNA

NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958

G

ELOVL fatty acid elongase 7

increases expression

alpha phellandrene results in increased expression of ELOVL7 mRNA

NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845

G

enolase 2

increases expression

alpha phellandrene results in increased expression of ENO2 mRNA

NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980

G

F-box protein 44

increases expression

alpha phellandrene results in increased expression of FBXO44 mRNA

NCBI chr 5:158,583,363...158,592,510
Ensembl chr 5:158,583,366...158,592,363

G

FGGY carbohydrate kinase domain containing

increases expression

alpha phellandrene results in increased expression of FGGY mRNA

NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017

G

FLVCR choline and heme transporter 1

decreases expression

alpha phellandrene results in decreased expression of FLVCR1 mRNA

NCBI chr13:102,586,263...102,608,647
Ensembl chr13:102,586,257...102,608,661

G

Fos proto-oncogene, AP-1 transcription factor subunit

increases expression

alpha phellandrene results in increased expression of FOS mRNA

NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036

G

forkhead box O1

increases expression

alpha phellandrene results in increased expression of FOXO1 mRNA

NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790

G

formyl peptide receptor 1

decreases expression

alpha phellandrene results in decreased expression of FPR1 mRNA

NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:58,747,246...58,756,559

G

ferritin heavy chain 1

increases expression

alpha phellandrene results in increased expression of FTH1 mRNA

NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424

G

ferritin light chain 1

increases expression

alpha phellandrene results in increased expression of FTL1 mRNA; alpha phellandrene results in increased expression of FTL2-PS mRNA

NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725
Ensembl chr10:95,936,387...95,939,725
Ensembl chr 2:95,936,387...95,939,725

G

FtsJ RNA 2'-O-methyltransferase 3

decreases expression

alpha phellandrene results in decreased expression of FTSJ3 mRNA

NCBI chr10:91,180,945...91,187,389
Ensembl chr10:91,180,696...91,187,397

G

frataxin

decreases expression

alpha phellandrene results in decreased expression of FXN mRNA

NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540

G

GABA type A receptor-associated protein

increases expression

alpha phellandrene results in increased expression of GABARAP mRNA

NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765

G

growth arrest and DNA-damage-inducible, alpha

increases expression

alpha phellandrene results in increased expression of GADD45A mRNA

NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115

G

growth arrest specific 5

decreases expression

alpha phellandrene results in decreased expression of GAS5 mRNA

NCBI chr13:73,303,611...73,306,932

G

guanylate binding protein family member 6

increases expression

alpha phellandrene results in increased expression of GBP6 mRNA

NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062
Ensembl chr14:4,730,453...4,839,062

G

GNAS complex locus

increases expression

alpha phellandrene results in increased expression of GNAS mRNA

NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262
Ensembl chr 3:163,071,417...163,127,262

G

G protein nucleolar 3

decreases expression

alpha phellandrene results in decreased expression of GNL3 mRNA

NCBI chr16:6,207,402...6,213,491
Ensembl chr16:6,207,402...6,213,392

G

G protein-coupled receptor 84

decreases expression

alpha phellandrene results in decreased expression of GPR84 mRNA

NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178

G

GREB1 like retinoic acid receptor coactivator

increases expression

alpha phellandrene results in increased expression of GREB1L mRNA

NCBI chr18:1,392,330...1,629,483
Ensembl chr18:1,392,725...1,628,067

G

glutamate ionotropic receptor NMDA type subunit associated protein 1

increases expression

alpha phellandrene results in increased expression of GRINA mRNA

NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366

G

glycosyltransferase-like domain containing 1

increases expression

alpha phellandrene results in increased expression of GTDC1 mRNA

NCBI chr 3:28,766,640...29,161,668
Ensembl chr 3:28,766,645...29,162,271

G

glycogen synthase 1

increases expression

alpha phellandrene results in increased expression of GYS1 mRNA

NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292

G

granzyme F

decreases expression

alpha phellandrene results in decreased expression of GZME mRNA

NCBI chr15:30,005,361...30,018,649
Ensembl chr15:30,007,267...30,018,649

G

H1.0 linker histone

increases expression

alpha phellandrene results in increased expression of H1F0 mRNA

NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694

G

H1.2 linker histone, cluster member

increases expression

alpha phellandrene results in increased expression of H1F2 mRNA

NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635

G

H2B clustered histone 18

increases expression

alpha phellandrene results in increased expression of H2BC18 mRNA

NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529

G

hydroxycarboxylic acid receptor 2

increases expression

alpha phellandrene results in increased expression of HCAR2 mRNA

NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504

G

HEAT repeat containing 1

decreases expression

alpha phellandrene results in decreased expression of HEATR1 mRNA

NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948

G

helicase with zinc finger 2

increases expression

alpha phellandrene results in increased expression of HELZ2 mRNA

NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159

G

HGH1 homolog

decreases expression

alpha phellandrene results in decreased expression of BRP16 mRNA

NCBI chr 7:108,091,918...108,094,740
Ensembl chr 7:108,091,951...108,094,737

G

hypoxia inducible lipid droplet-associated

increases expression

alpha phellandrene results in increased expression of HILPDA mRNA

NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557

G

HIVEP zinc finger 3

increases expression

alpha phellandrene results in increased expression of HIVEP3 mRNA

NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795

G

heat shock protein family A (Hsp70) member 2

increases expression

alpha phellandrene results in increased expression of HSPA2 mRNA

NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287

G

heat shock protein family A (Hsp70) member 5

decreases expression

alpha phellandrene results in decreased expression of HSPA5 mRNA

NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891

G

heat shock protein family A (Hsp70) member 8

decreases expression

alpha phellandrene results in decreased expression of HSPA8 mRNA

NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259

G

inhibitor of DNA binding 2

increases expression

alpha phellandrene results in increased expression of ID2 mRNA

NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

alpha phellandrene results in decreased expression of IDI1 mRNA

NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357

G

interferon induced with helicase C domain 1

increases expression

alpha phellandrene results in increased expression of IFIH1 mRNA

NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456

G

interferon, lambda 3

increases expression

alpha phellandrene results in increased expression of IFNL3 mRNA

NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096

G

interleukin 2 receptor subunit alpha

decreases expression

alpha phellandrene results in decreased expression of IL2RA mRNA

NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697

G

interleukin 36, gamma

decreases expression

alpha phellandrene results in decreased expression of IL36G mRNA

NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480

G

interferon regulatory factor 5

increases expression

alpha phellandrene results in increased expression of IRF5 mRNA

NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267

G

interferon regulatory factor 7

increases expression

alpha phellandrene results in increased expression of IRF7 mRNA

NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832

G

immunity-related GTPase M

increases expression

alpha phellandrene results in increased expression of IRGM2 mRNA

NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578

G

integrin subunit alpha L

increases expression

alpha phellandrene results in increased expression of ITGAL mRNA

NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732

G

jagunal homolog 1

decreases expression

alpha phellandrene results in decreased expression of JAGN1 mRNA

NCBI chr 4:146,591,577...146,596,287
Ensembl chr 4:146,591,510...146,596,288

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

alpha phellandrene results in increased expression of JUN mRNA

NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656

G

KN motif and ankyrin repeat domains 2

decreases expression

alpha phellandrene results in decreased expression of KANK2 mRNA

NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900

G

lysine demethylase 7A

increases expression

alpha phellandrene results in increased expression of KDM7A mRNA

NCBI chr 4:67,899,407...67,974,264
Ensembl chr 4:67,904,307...67,966,998

G

kelch-like family member 24

increases expression

alpha phellandrene results in increased expression of KLHL24 mRNA

NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636

G

LIM domain and actin binding 1

increases expression

alpha phellandrene results in increased expression of LIMA1 mRNA

NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473

G

LLGL scribble cell polarity complex component 2

decreases expression

alpha phellandrene results in decreased expression of LLGL2 mRNA

NCBI chr10:101,050,978...101,086,527
Ensembl chr10:101,051,408...101,086,525

G

small nucleolar RNA MBII-202

decreases expression

alpha phellandrene results in decreased expression of SNORD68 mRNA

NCBI chr19:51,154,626...51,154,708
Ensembl chr19:51,154,626...51,154,708

G

LIM domain containing preferred translocation partner in lipoma

increases expression

alpha phellandrene results in increased expression of LPP mRNA

NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597

G

listerin E3 ubiquitin protein ligase 1

decreases expression

alpha phellandrene results in decreased expression of LTN1 mRNA

NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886

G

lymphocyte antigen 6 family member H

decreases expression

alpha phellandrene results in decreased expression of LY6C1 mRNA; alpha phellandrene results in decreased expression of LY6C2 mRNA

NCBI chr 7:107,258,779...107,261,270
Ensembl chr 7:107,258,779...107,261,454

G

mitogen-activated protein kinase kinase 6

increases expression

alpha phellandrene results in increased expression of MAP2K6 mRNA

NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293

G

methionine adenosyltransferase 2A

decreases expression

alpha phellandrene results in decreased expression of MAT2A mRNA

NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493

G

mast cell-expressed membrane protein 1

increases expression

alpha phellandrene results in increased expression of MCEMP1 mRNA

NCBI chr12:1,721,781...1,727,350
Ensembl chr12:1,718,730...1,725,986

G

mediator of DNA damage checkpoint 1

increases expression

alpha phellandrene results in increased expression of MDC1 protein

NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240

G

midasin AAA ATPase 1

decreases expression

alpha phellandrene results in decreased expression of MDN1 mRNA

NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332

G

mediator complex subunit 29

decreases expression

alpha phellandrene results in decreased expression of MED29 mRNA

NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365

G

mediator complex subunit 31

increases expression

alpha phellandrene results in increased expression of MED31 mRNA

NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326

G

mitochondria-localized glutamic acid-rich protein

increases expression

alpha phellandrene results in increased expression of MGARP mRNA

NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612

G

alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase

decreases expression

alpha phellandrene results in decreased expression of MGAT2 mRNA

NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177

G

O-6-methylguanine-DNA methyltransferase

decreases expression

alpha phellandrene results in decreased expression of MGMT protein

NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756

G

MINDY lysine 48 deubiquitinase 2

increases expression

alpha phellandrene results in increased expression of MINDY2 mRNA

NCBI chr 8:71,268,274...71,327,698
Ensembl chr 8:71,256,447...71,328,453

G

microRNA 375

increases expression

alpha phellandrene results in increased expression of MIR375 mRNA

NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985

G

major histocompatibility complex, class I-related

increases expression

alpha phellandrene results in increased expression of MR1 mRNA

NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970

G

mitochondrial ribosomal protein L20

decreases expression

alpha phellandrene results in decreased expression of MRPL20 mRNA

NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492

G

mitochondrial ribosomal protein L45

increases expression

alpha phellandrene results in increased expression of MRPL45 mRNA

NCBI chr10:82,308,650...82,320,474
Ensembl chr10:82,308,427...82,320,474

G

MRT4 homolog, ribosome maturation factor

decreases expression

alpha phellandrene results in decreased expression of MRTO4 mRNA

NCBI chr 5:151,601,780...151,608,533
Ensembl chr 5:151,601,780...151,608,287

G

membrane spanning 4-domains A3

decreases expression

alpha phellandrene results in decreased expression of MS4A3 mRNA

NCBI chr 1:208,462,300...208,480,129
Ensembl chr 1:208,462,301...208,480,101

G

mechanistic target of rapamycin kinase

decreases expression

alpha phellandrene results in decreased expression of MTOR protein

NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311

G

metaxin 3

decreases expression

alpha phellandrene results in decreased expression of MTX3 mRNA

NCBI chr 2:24,066,332...24,079,708
Ensembl chr 2:24,066,365...24,079,670

G

mucin 13, cell surface associated

decreases expression

alpha phellandrene results in decreased expression of MUC13 mRNA

NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727

G

MX dynamin like GTPase 2

increases expression

alpha phellandrene results in increased expression of MX2 mRNA

NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342

G

max dimerization protein 1

increases expression

alpha phellandrene results in increased expression of MXD1 mRNA

NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751

G

myeloid-associated differentiation marker

increases expression

alpha phellandrene results in increased expression of MYADM mRNA

NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035

G

MYB binding protein 1a

decreases expression

alpha phellandrene results in decreased expression of MYBBP1A mRNA

NCBI chr10:57,056,897...57,067,258
Ensembl chr10:57,056,874...57,067,255

G

myosin IXA

increases expression

alpha phellandrene results in increased expression of MYO9A mRNA

NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514

G

nicotinamide phosphoribosyltransferase

increases expression

alpha phellandrene results in increased expression of NAMPT mRNA

NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100

G

N-acetyltransferase 10

decreases expression

alpha phellandrene results in decreased expression of NAT10 mRNA

NCBI chr 3:90,111,643...90,149,891
Ensembl chr 3:90,111,645...90,149,927

G

NDRG family member 2

increases expression

alpha phellandrene results in increased expression of NDRG2 mRNA

NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626

G

nuclear factor, interleukin 3 regulated

increases expression

alpha phellandrene results in increased expression of NFIL3 mRNA

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858

G

NFKB inhibitor alpha

increases expression

alpha phellandrene results in increased expression of NFKBIA mRNA

NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941

G

NHP2 ribonucleoprotein

decreases expression

alpha phellandrene results in decreased expression of NHP2 mRNA

NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545

G

nucleolar protein 10

decreases expression

alpha phellandrene results in decreased expression of NOL10 mRNA

NCBI chr 6:40,144,217...40,225,353
Ensembl chr 6:40,144,235...40,225,353

G

nucleolar protein 8

decreases expression

alpha phellandrene results in decreased expression of NOL8 mRNA

NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848

G

nucleolar and coiled-body phosphoprotein 1

decreases expression

alpha phellandrene results in decreased expression of NOLC1 mRNA

NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088

G

NOP2 nucleolar protein

decreases expression

alpha phellandrene results in decreased expression of NOP2 mRNA

NCBI chr 4:157,932,731...157,944,462
Ensembl chr 4:157,932,716...157,944,459

G

NOP56 ribonucleoprotein

decreases expression

alpha phellandrene results in decreased expression of NOP56 mRNA

NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841

G

nitric oxide synthase 2

increases expression

alpha phellandrene results in increased expression of NOS2 mRNA

NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210

G

nuclear transport factor 2-like export factor 2

increases expression

alpha phellandrene results in increased expression of NXT2 mRNA

NCBI chr X:105,855,616...105,862,902
Ensembl chr X:105,855,608...105,862,899

G

2'-5' oligoadenylate synthetase 1A

increases expression

alpha phellandrene results in increased expression of OAS1A mRNA; alpha phellandrene results in increased expression of OAS1B mRNA

NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517

G

2'-5'-oligoadenylate synthetase 3

increases expression

alpha phellandrene results in increased expression of OAS3 mRNA

NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781

G

oxysterol binding protein-like 9

increases expression

alpha phellandrene results in increased expression of OSBPL9 mRNA

NCBI chr 5:123,819,106...123,962,213
Ensembl chr 5:123,819,104...123,962,196

G

PABIR family member 2

increases expression

alpha phellandrene results in increased expression of PABIR2 mRNA

NCBI chr X:132,989,124...133,015,625
Ensembl chr X:132,989,124...133,015,580

G

poly (ADP-ribose) polymerase family, member 14

increases expression

alpha phellandrene results in increased expression of PARP14 mRNA

NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916

G

prenylcysteine oxidase 1 like

decreases expression

alpha phellandrene results in decreased expression of PCYOX1L mRNA

NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327

G

phosphodiesterase 3B

increases expression

alpha phellandrene results in increased expression of PDE3B mRNA

NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:168,607,022...168,769,334

G

phosphoethanolamine/phosphocholine phosphatase 1

increases expression

alpha phellandrene results in increased expression of PHOSPHO1 mRNA

NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342

G

phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta

increases expression

alpha phellandrene results in increased expression of PIK3CB mRNA

NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663

G

phospholipase D family, member 4

increases expression

alpha phellandrene results in increased expression of PLD4 mRNA

NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376

G

plexin domain containing 1

increases expression

alpha phellandrene results in increased expression of PLXDC1 mRNA

NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130

G

proline-rich nuclear receptor coactivator 2

increases expression

alpha phellandrene results in increased expression of PNRC2 mRNA

NCBI chr 5:148,103,966...148,106,950
Ensembl chr 5:148,095,699...148,107,242
Ensembl chr 5:148,095,699...148,107,242

G

RNA polymerase I subunit B

decreases expression

alpha phellandrene results in decreased expression of POLR1B mRNA

NCBI chr 3:116,333,910...116,358,385
Ensembl chr 3:116,333,889...116,358,379

G

POP1 homolog, ribonuclease P/MRP subunit

decreases expression

alpha phellandrene results in decreased expression of POP1 mRNA

NCBI chr 7:65,705,348...65,733,143
Ensembl chr 7:65,705,368...65,733,141

G

peter pan homolog

decreases expression

alpha phellandrene results in decreased expression of PPAN mRNA

NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938

G

phosphoribosyl pyrophosphate amidotransferase

decreases expression

alpha phellandrene results in decreased expression of PPAT mRNA

NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144

G

protein phosphatase, Mg2+/Mn2+ dependent, 1K

increases expression

alpha phellandrene results in increased expression of PPM1K mRNA

NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:87,612,204...87,636,152

G

protein phosphatase 2, regulatory subunit B', gamma

increases expression

alpha phellandrene results in increased expression of PPP2R5C mRNA

NCBI chr 6:129,461,689...129,598,344
Ensembl chr 6:129,461,648...129,598,346

G

PPARG related coactivator 1

decreases expression

alpha phellandrene results in decreased expression of PPRC1 mRNA

NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587

G

protein kinase, DNA-activated, catalytic subunit

decreases expression

alpha phellandrene results in decreased expression of PRKDC protein

NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952

G

serine protease 1

decreases expression

alpha phellandrene results in decreased expression of TRY10 mRNA

NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792

G

polypyrimidine tract binding protein 3

increases expression

alpha phellandrene results in increased expression of PTBP3 mRNA

NCBI chr 5:74,313,367...74,399,439
Ensembl chr 5:74,315,101...74,399,791

G

protein tyrosine phosphatase, mitochondrial 1

decreases expression

alpha phellandrene results in decreased expression of PTPMT1 mRNA

NCBI chr 3:76,889,922...76,899,427
Ensembl chr 3:76,889,922...76,899,427

G

protein tyrosine phosphatase, non-receptor type 7

decreases expression

alpha phellandrene results in decreased expression of PTPN7 mRNA

NCBI chr13:46,570,904...46,584,048
Ensembl chr13:46,571,712...46,583,308

G

pseudouridine synthase 7

decreases expression

alpha phellandrene results in decreased expression of PUS7 mRNA

NCBI chr 4:11,360,169...11,401,139
Ensembl chr 4:11,360,188...11,401,172

G

pseudouridine synthase 7 like

decreases expression

alpha phellandrene results in decreased expression of PUS7L mRNA

NCBI chr 7:125,659,507...125,706,582
Ensembl chr 7:125,659,507...125,682,333

G

RAD51 paralog C

increases expression

alpha phellandrene results in increased expression of RAD51C mRNA

NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,205,032...72,231,248

G

RAP2B, member of RAS oncogene family

increases expression

alpha phellandrene results in increased expression of RAP2B mRNA

NCBI chr 2:145,599,714...145,600,265
Ensembl chr 2:145,599,116...145,603,069

G

RNA binding motif protein 12B

decreases expression

alpha phellandrene results in decreased expression of RBM12B2 mRNA

NCBI chr 5:25,597,405...25,610,324
Ensembl chr 5:25,590,493...25,611,245

G

recombination signal binding protein for immunoglobulin kappa J region

increases expression

alpha phellandrene results in increased expression of RBPJ mRNA

NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353

G

RNA terminal phosphate cyclase-like 1

decreases expression

alpha phellandrene results in decreased expression of RCL1 mRNA

NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315

G

similar to RIKEN cDNA 3110043O21

increases expression

alpha phellandrene results in increased expression of C9ORF72 mRNA

NCBI chr 5:49,766,340...49,791,434
Ensembl chr 5:49,766,325...49,791,408

G

Rho-related BTB domain containing 2

increases expression

alpha phellandrene results in increased expression of RHOBTB2 mRNA

NCBI chr15:44,868,251...44,888,436
Ensembl chr15:44,870,376...44,888,651

G

RNA sensor RIG-1

increases expression

alpha phellandrene results in increased expression of RIGI mRNA

NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819

G

ring finger protein 141

increases expression

alpha phellandrene results in increased expression of RNF141 mRNA

NCBI chr 1:164,933,972...164,957,081
Ensembl chr 1:164,931,077...164,957,118

G

ring finger protein 19B

increases expression

alpha phellandrene results in increased expression of RNF19B mRNA

NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380

G

RP2 activator of ARL3 GTPase

increases expression

alpha phellandrene results in increased expression of RP2 mRNA

NCBI chr X:1,872,582...1,916,704
Ensembl chr X:1,873,306...1,916,688

G

ribonuclease P/MRP subunit p14

decreases expression

alpha phellandrene results in decreased expression of RPP14 mRNA

NCBI chr15:16,837,796...16,847,970
Ensembl chr15:16,836,859...16,852,101
Ensembl chr15:16,836,859...16,852,101

G

ribonuclease P/MRP subunit p38

decreases expression

alpha phellandrene results in decreased expression of RPP38 mRNA

NCBI chr17:74,914,066...74,917,742
Ensembl chr17:74,908,932...74,927,431

G

ribosomal protein S12

decreases expression

alpha phellandrene results in decreased expression of RPS12 mRNA

NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014

G

RAS related

increases expression

alpha phellandrene results in increased expression of RRAS mRNA

NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357

G

ribosomal RNA processing 12

decreases expression

alpha phellandrene results in decreased expression of RRP12 mRNA

NCBI chr 1:240,672,378...240,705,992
Ensembl chr 1:240,672,382...240,706,018

G

ribosomal RNA processing 15 homolog

decreases expression

alpha phellandrene results in decreased expression of RRP15 mRNA

NCBI chr13:98,276,276...98,299,357
Ensembl chr13:98,276,134...98,299,370

G

radical S-adenosyl methionine domain containing 2

increases expression

alpha phellandrene results in increased expression of RSAD2 mRNA

NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699

G

retrotransposon-like 1

decreases expression

alpha phellandrene results in decreased expression of RTL1 mRNA

NCBI chr 6:128,543,904...128,549,384
Ensembl chr 6:128,543,939...128,549,182

G

retrotransposon Gag like 8A

increases expression

alpha phellandrene results in increased expression of RTL8A mRNA

NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240

G

receptor (chemosensory) transporter protein 4

increases expression

alpha phellandrene results in increased expression of RTP4 mRNA

NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437

G

rubicon like autophagy enhancer

increases expression

alpha phellandrene results in increased expression of RUBCNL mRNA

NCBI chr15:50,332,458...50,377,494
Ensembl chr15:50,332,418...50,400,849

G

SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1

increases expression

alpha phellandrene results in increased expression of SAMHD1 mRNA

NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386

G

spermidine/spermine N1-acetyl transferase 1

increases expression

alpha phellandrene results in increased expression of SAT1 mRNA

NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813

G

SDA1 domain containing 1

decreases expression

alpha phellandrene results in decreased expression of SDAD1 mRNA

NCBI chr14:15,741,489...15,768,271
Ensembl chr14:15,741,434...15,771,066

G

SEC14-like lipid binding 1

increases expression

alpha phellandrene results in increased expression of SEC14L1 mRNA

NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068

G

selenium binding protein 1

increases expression

alpha phellandrene results in increased expression of SELENBP1 mRNA; alpha phellandrene results in increased expression of SELENBP2 mRNA

NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594

G

semaphorin 3C

decreases expression

alpha phellandrene results in decreased expression of SEMA3C mRNA

NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534

G

SUMO specific peptidase 2

decreases expression

alpha phellandrene results in decreased expression of SENP2 mRNA

NCBI chr11:78,981,429...79,018,274
Ensembl chr11:78,981,432...79,018,238

G

septin 8

increases expression

alpha phellandrene results in increased expression of SEPT8 mRNA

NCBI chr10:37,684,649...37,713,704
Ensembl chr10:37,684,639...37,713,174

G

SERTA domain containing 3

increases expression

alpha phellandrene results in increased expression of SERTAD3 mRNA

NCBI chr 1:82,763,535...82,767,271
Ensembl chr 1:82,763,149...82,769,001

G

Set nuclear proto-oncogene

decreases expression

alpha phellandrene results in decreased expression of SET mRNA

NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567

G

stratifin

increases expression

alpha phellandrene results in increased expression of SFN protein

NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314

G

SAGA complex associated factor 29

decreases expression

alpha phellandrene results in decreased expression of SGF29 mRNA

NCBI chr 1:181,238,458...181,271,931
Ensembl chr 1:181,238,468...181,274,781

G

shugoshin 2

increases expression

alpha phellandrene results in increased expression of SGO2A mRNA

NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229

G

sigma non-opioid intracellular receptor 1

decreases expression

alpha phellandrene results in decreased expression of SIGMAR1 mRNA

NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017

G

solute carrier family 1 member 5

decreases expression

alpha phellandrene results in decreased expression of SLC1A5 mRNA

NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952

G

solute carrier family 35, member B1

decreases expression

alpha phellandrene results in decreased expression of SLC35B1 mRNA

NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,327,945...80,335,274

G

solute carrier family 35 member D1

decreases expression

alpha phellandrene results in decreased expression of SLC35D1 mRNA

NCBI chr 5:117,928,628...117,981,289
Ensembl chr 5:117,934,352...117,981,311

G

solute carrier family 44 member 1

increases expression

alpha phellandrene results in increased expression of SLC44A1 mRNA

NCBI chr 5:68,061,941...68,241,912
Ensembl chr 5:68,063,618...68,241,909

G

solute carrier family 44, member 3

increases expression

alpha phellandrene results in increased expression of SLC44A3 mRNA

NCBI chr 2:209,552,138...209,628,182
Ensembl chr 2:209,552,144...209,629,044

G

solute carrier family 7 member 1

decreases expression

alpha phellandrene results in decreased expression of SLC7A1 mRNA

NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849

G

solute carrier family 7 member 11

decreases expression

alpha phellandrene results in decreased expression of SLC7A11 mRNA

NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536

G

solute carrier family 7 member 6

decreases expression

alpha phellandrene results in decreased expression of SLC7A6 mRNA

NCBI chr19:34,073,472...34,100,268
Ensembl chr19:34,074,286...34,100,268

G

schlafen family member 5

increases expression

alpha phellandrene results in increased expression of SLFN4 mRNA; alpha phellandrene results in increased expression of SLFN5 mRNA

NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109

G

small integral membrane protein 14

increases expression

alpha phellandrene results in increased expression of SMIM14 mRNA

NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760

G

spermine oxidase

increases expression

alpha phellandrene results in increased expression of SMOX mRNA

NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
Ensembl chr X:118,731,900...118,765,710

G

small nucleolar RNA, H/ACA box 20

decreases expression

alpha phellandrene results in decreased expression of SNORA20 mRNA

NCBI chr 1:47,830,540...47,830,669
Ensembl chr 8:71,142,787...71,142,916

G

small nucleolar RNA, H/ACA box 21

decreases expression

alpha phellandrene results in decreased expression of SNORA21 mRNA

NCBI chr10:82,775,114...82,775,249
Ensembl chr10:82,775,114...82,775,249

G

small nucleolar RNA, H/ACA box 26

decreases expression

alpha phellandrene results in decreased expression of SNORA26 mRNA

NCBI chr14:34,127,640...34,127,760
Ensembl chr14:34,127,640...34,127,760

G

small nucleolar RNA, H/ACA box 3A

decreases expression

alpha phellandrene results in decreased expression of SNORA3 mRNA

NCBI chr 1:163,540,664...163,540,793
Ensembl chr 1:163,540,664...163,540,793

G

small nucleolar RNA, H/ACA box 44

decreases expression

alpha phellandrene results in decreased expression of SNORA44 mRNA

NCBI chr 4:126,415,989...126,416,119
Ensembl chr 4:126,415,989...126,416,119

G

small nucleolar RNA, H/ACA box 61

decreases expression

alpha phellandrene results in decreased expression of SNORA61 mRNA

NCBI chr 5:144,506,420...144,506,549
Ensembl chr 5:144,506,420...144,506,549

G

small nucleolar RNA, H/ACA box 73b

decreases expression

alpha phellandrene results in decreased expression of SNORA73B mRNA

NCBI chr 5:144,545,179...144,545,382
Ensembl chr 5:144,545,179...144,545,382

G

small nucleolar RNA, H/ACA box 75

decreases expression

alpha phellandrene results in decreased expression of SNORA75 mRNA

NCBI chr 9:87,000,248...87,000,384
Ensembl chr 9:87,000,248...87,000,384

G

small nucleolar RNA, C/D box 22

decreases expression

alpha phellandrene results in decreased expression of SNORD22 mRNA

NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923

G

small nucleolar RNA, C/D box 34

decreases expression

alpha phellandrene results in decreased expression of SNORD34 mRNA

NCBI chr 8:115,045,817...115,045,883
Ensembl chr 8:115,045,817...115,045,883

G

small nucleolar RNA, C/D box 52

decreases expression

alpha phellandrene results in decreased expression of SNORD52 mRNA

NCBI chr20:3,878,412...3,878,477
Ensembl chr20:3,878,412...3,878,477

G

small nucleolar RNA, C/D box 82

decreases expression

alpha phellandrene results in decreased expression of SNORD82 mRNA

NCBI chr 9:87,004,515...87,004,586
Ensembl chr 9:87,004,515...87,004,586

G

small nucleolar RNA, C/D box 87

decreases expression

alpha phellandrene results in decreased expression of SNORD87 mRNA

NCBI chr 5:9,297,489...9,297,573
Ensembl chr 5:9,297,489...9,297,573

G

small nucleolar RNA, C/D box 95

decreases expression

alpha phellandrene results in decreased expression of SNORD95 mRNA

NCBI chr10:33,171,983...33,172,050
Ensembl chr10:33,171,983...33,172,050

G

small nucleolar RNA, C/D box 96A

decreases expression

alpha phellandrene results in decreased expression of SNORD96A mRNA

NCBI chr10:33,171,093...33,171,172
Ensembl chr10:33,171,093...33,171,172

G

small nuclear ribonucleoprotein D2 polypeptide

decreases expression

alpha phellandrene results in decreased expression of SNRPD2 mRNA

NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351
Ensembl chr20:78,798,377...78,803,351

G

SP100 nuclear antigen

increases expression

alpha phellandrene results in increased expression of SP100 mRNA

NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034

G

SP140 nuclear body protein

increases expression

alpha phellandrene results in increased expression of SP140 mRNA

NCBI chr 9:86,224,472...86,274,724
Ensembl chr 9:86,224,513...86,274,542

G

SPC25 component of NDC80 kinetochore complex

increases expression

alpha phellandrene results in increased expression of SPC25 mRNA

NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959

G

sprouty-related, EVH1 domain containing 3

increases expression

alpha phellandrene results in increased expression of SPRED3 mRNA

NCBI chr 1:84,458,779...84,470,425
Ensembl chr 1:84,459,314...84,470,249

G

sorcin

increases expression

alpha phellandrene results in increased expression of SRI mRNA

NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077

G

spermidine synthase

decreases expression

alpha phellandrene results in decreased expression of SRM mRNA

NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405

G

serine racemase

increases expression

alpha phellandrene results in increased expression of SRR mRNA

NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011

G

serine and arginine rich splicing factor 7

decreases expression

alpha phellandrene results in decreased expression of SRSF7 mRNA

NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965

G

signal sequence receptor subunit 4

decreases expression

alpha phellandrene results in decreased expression of SSR4 mRNA

NCBI chr X:151,524,191...151,528,218
Ensembl chr X:151,524,009...151,528,202

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5

decreases expression

alpha phellandrene results in decreased expression of ST8SIA5 mRNA

NCBI chr18:70,736,395...70,802,537
Ensembl chr18:70,736,602...70,797,789

G

STARD3 N-terminal like

increases expression

alpha phellandrene results in increased expression of STARD3NL mRNA

NCBI chr17:45,583,278...45,617,226
Ensembl chr17:45,583,266...45,617,226

G

StAR-related lipid transfer domain containing 5

increases expression

alpha phellandrene results in increased expression of STARD5 mRNA

NCBI chr 1:137,606,151...137,616,017
Ensembl chr 1:137,606,177...137,616,469

G

signal transducer and activator of transcription 1

increases expression

alpha phellandrene results in increased expression of STAT1 mRNA

NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540

G

signal transducer and activator of transcription 2

increases expression

alpha phellandrene results in increased expression of STAT2 mRNA

NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967

G

Suv3 like RNA helicase

decreases expression

alpha phellandrene results in decreased expression of SUPV3L1 mRNA

NCBI chr20:30,378,542...30,399,076
Ensembl chr20:30,378,550...30,399,054

G

TATA-box binding protein associated factor, RNA polymerase I subunit D

decreases expression

alpha phellandrene results in decreased expression of TAF1D mRNA

NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618

G

thromboxane A synthase 1

decreases expression

alpha phellandrene results in decreased expression of TBXAS1 mRNA

NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096

G

transcription elongation factor A N-terminal and central domain containing

increases expression

alpha phellandrene results in increased expression of TCEANC mRNA

NCBI chr X:27,952,539...27,961,038
Ensembl chr X:27,952,457...27,960,940

G

t-complex 11 like 2

increases expression

alpha phellandrene results in increased expression of TCP11L2 mRNA

NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095

G

tectonic family member 3

increases expression

alpha phellandrene results in increased expression of TCTN3 mRNA

NCBI chr 1:239,414,003...239,425,273
Ensembl chr 1:239,415,203...239,425,272

G

tudor domain containing 7

increases expression

alpha phellandrene results in increased expression of TDRD7 mRNA

NCBI chr 5:60,238,742...60,312,548
Ensembl chr 5:60,238,678...60,312,544

G

TEPSIN, adaptor related protein complex 4 accessory protein

decreases expression

alpha phellandrene results in decreased expression of TEPSIN mRNA

NCBI chr10:105,373,939...105,381,310
Ensembl chr10:105,373,941...105,382,266

G

testis associated actin remodelling kinase 2

increases expression

alpha phellandrene results in increased expression of TESK2 mRNA

NCBI chr 5:130,178,715...130,270,594
Ensembl chr 5:130,185,033...130,271,292

G

transcription factor AP-4

decreases expression

alpha phellandrene results in decreased expression of TFAP4 mRNA

NCBI chr10:11,001,338...11,019,386
Ensembl chr10:11,002,911...11,019,386

G

tRNA-histidine guanylyltransferase 1-like

decreases expression

alpha phellandrene results in decreased expression of THG1L mRNA

NCBI chr10:30,387,929...30,396,579
Ensembl chr10:30,387,940...30,396,687

G

translocase of inner mitochondrial membrane 10

decreases expression

alpha phellandrene results in decreased expression of TIMM10 mRNA

NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940

G

transmembrane protein 120A

decreases expression

alpha phellandrene results in decreased expression of TMEM120A mRNA

NCBI chr12:20,942,243...20,950,908
Ensembl chr12:20,942,439...20,990,316

G

transmembrane protein 97

decreases expression

alpha phellandrene results in decreased expression of TMEM97 mRNA

NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730

G

thymosin, beta 10

increases expression

alpha phellandrene results in increased expression of TMSB10 mRNA

NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028

G

thymosin beta 4, X-linked

increases expression

alpha phellandrene results in increased expression of TMSB4X mRNA

NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667
Ensembl chr10:27,128,610...27,146,667

G

tumor protein p53

increases phosphorylation
decreases expression
affects localization
increases expression

alpha phellandrene results in increased phosphorylation of TRP53 protein
alpha phellandrene results in decreased expression of TRP53 protein
alpha phellandrene affects the localization of TP53 protein
alpha phellandrene results in increased expression of TRP53 protein modified form

PMID:24861204 PMID:25649747

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

tumor protein D52

increases expression

alpha phellandrene results in increased expression of TPD52 mRNA

NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622

G

tropomyosin 4

increases expression

alpha phellandrene results in increased expression of TPM4 mRNA

NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984

G

tripartite motif-containing 21

increases expression

alpha phellandrene results in increased expression of TRIM21 mRNA

NCBI chr 1:156,964,896...156,987,504
Ensembl chr 1:156,964,913...156,987,440

G

TSPO associated protein 1

increases expression

alpha phellandrene results in increased expression of TSPOAP1 mRNA

NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412

G

TSR1, ribosome maturation factor

decreases expression

alpha phellandrene results in decreased expression of TSR1 mRNA

NCBI chr10:59,760,420...59,771,868
Ensembl chr10:59,760,409...59,771,864

G

thiosulfate sulfurtransferase like domain containing 3

increases expression

alpha phellandrene results in increased expression of TSTD3 mRNA

NCBI chr 5:35,294,652...35,304,093
Ensembl chr 5:35,294,645...35,304,101

G

tetratricopeptide repeat domain 27

decreases expression

alpha phellandrene results in decreased expression of TTC27 mRNA

NCBI chr 6:20,558,756...20,702,126
Ensembl chr 6:20,558,756...20,702,115

G

ubiquitin associated and SH3 domain containing, A

decreases expression

alpha phellandrene results in decreased expression of UBASH3A mRNA

NCBI chr20:9,291,471...9,334,685
Ensembl chr20:9,292,139...9,329,224

G

ubiquitin-conjugating enzyme E2H

increases expression

alpha phellandrene results in increased expression of UBE2H mRNA

NCBI chr 4:58,834,674...58,930,156
Ensembl chr 4:58,834,674...58,930,156

G

URB2 ribosome biogenesis homolog

decreases expression

alpha phellandrene results in decreased expression of URB2 mRNA

NCBI chr19:52,011,019...52,036,607
Ensembl chr19:52,011,112...52,036,597

G

ubiquitin specific peptidase 18

increases expression

alpha phellandrene results in increased expression of USP18 mRNA

NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144

G

ubiquitin specific peptidase 22

increases expression

alpha phellandrene results in increased expression of USP22 mRNA

NCBI chr10:45,828,619...45,855,468
Ensembl chr10:45,828,622...45,855,497

G

ubiquitin specific peptidase 36

decreases expression

alpha phellandrene results in decreased expression of USP36 mRNA

NCBI chr10:103,497,349...103,528,877
Ensembl chr10:103,497,349...103,528,877

G

UTP20 small subunit processome component

decreases expression

alpha phellandrene results in decreased expression of UTP20 mRNA

NCBI chr 7:23,134,630...23,215,639
Ensembl chr 7:23,134,637...23,215,632

G

WD repeat domain 12

decreases expression

alpha phellandrene results in decreased expression of WDR12 mRNA

NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469

G

WD repeat domain 3

decreases expression

alpha phellandrene results in decreased expression of WDR3 mRNA

NCBI chr 2:187,505,816...187,528,432
Ensembl chr 2:187,505,816...187,528,432

G

WD repeat domain 74

decreases expression

alpha phellandrene results in decreased expression of WDR74 mRNA